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ABSTRACT 
 
Jurcsisn, Jennifer, Ph. D., Biomedical Sciences Ph.D. Program, Wright State University, 
2019. Biomarker-performance associations during nutritional and exercise intervention in 
Air Force personnel. 
 
 
This study evaluated the combined effects of an exercise intervention and 
nutritional supplement on biomarkers of stress and resilience, and the relationships of 
those markers with physical and cognitive performance. 130 healthy Active-Duty Air 
Force (AF) personnel were recruited to participate in a double-blind, placebo controlled 
12-week exercise and nutritional intervention. Serum was collected at basal and high 
stress conditions pre- and post-intervention to track the following biomarkers: cortisol, 
dehydroepiandrosterone-sulfate (DHEA-S), norepinephrine (NE), neuropeptide Y (NPY), 
and serotonin. The exercise intervention significantly attenuated the cortisol response and 
peak stress cortisol levels. The nutritional intervention decreased peak stress NE. The 
selected biomarkers were not universally correlated with performance measures. NPY, 
NE, and cortisol levels showed strong relationships with several dimensions of physical 
performance during stress, though resting NPY and NE levels did not. Few correlations 
were observed between biomarkers and cognitive performance. We conclude that these 
interventions had mixed and modest effects on biomarker levels of stress and resilience 
and that their relationships with performance is dependent on task type and stress 
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condition. For future research, we recommend measuring additional biomarkers and 
tailoring interventions to the individual subject for greater efficacy. 
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BACKGROUND 
Air Force Readiness 
The Air Force (AF) places high demand on Airmen in their daily duties, both 
physically and cognitively. To ensure mission success, Airmen are expected to perform at 
their peak regardless of adverse working conditions such as physical exhaustion, heat 
stress, sleep deprivation, dehydration, and inadequate nutrition. Acquiring and sustaining 
such performance requires these Airmen to regularly engage in rigorous exercise training 
and job-skills education. However, as the wide-range of AF operations become more 
complex, competitive, and technologically advanced, the AF must continuously develop 
innovative methods to get the most out of the everyday training and maximize Airmen 
readiness. Biomarkers may have the capacity to serve as a tool with which to develop 
these approaches. With the understanding of biomarkers and their associations with 
performance, fitness, and nutrition, Airmen’s physiology may be better monitored, 
analyzed, and appropriately adjusted. Providing the tools and interventions to optimize 
Airmen performance will lead to improved work quality and decision-making. This study 
aims to lay the groundwork on which these physiological monitoring, assessment, and 
enhancement strategies may be based. 
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Nutritional Supplementation  
It is perhaps unsurprising that the AF is interested in leveraging nutrition as a 
means to improve performance. Potentially due to the demanding, high-stress nature of 
military work, service members already report taking more nutritional supplements for 
performance enhancement than their civilian counterparts. This has incited research 
which suggests that targeted nutritional supplements and specialized exercise training 
regimens can, in fact, enhance physical and cognitive performance in Airmen (Bovill, 
2003; Lieberman, 2010; Lennemann, 2013). This is consistent with clinical studies which 
report that over-the-counter (OTC) supplements such as caffeine and tyrosine can 
improve cognitive faculties such as vigilance and stress resilience (Lieberman, 2003). 
Likewise, protein-based supplements can improve physical attributes such as post-
exercise muscle recovery (Flakoll, 2004; Kraemer, 2007). 
With the ever-increasing demand the AF places on soldiers and the growing body 
of evidence that performance may be enhanced with relatively simple, non-invasive 
measures, it stands to reason that the AF must develop and evaluate targeted nutrition 
programs for the benefit of its workers and the military at large. 
Our collaborators at Abbott Nutrition (makers of Ensure®, Pedialyte®, EAS®, 
and Myoplex®) have developed a multi-purpose liquid nutritional supplement to promote 
cognitive function and improve muscle recovery. This supplement was designed 
specifically to meet the complex performance needs of Airmen, many of whom work jobs 
that are physically and cognitively challenging (e.g., field medic, pilot, combat controller, 
flight line mechanic, etc.). This supplement was created by assembling previously FDA-
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approved nutrient formulas that are available in some of Abbott’s existing OTC products. 
A primary goal of the current research was to test the effectiveness of this supplement in 
its target population. 
Exercise Intervention 
Nutritional supplements are typically used in conjunction with exercise programs 
to further boost performance gains. While other branches of the military endorse and 
utilize formal exercise interventions for their soldiers (e.g., the Army’s Physical 
Readiness Training, or the Navy Operational Fitness and Fueling System), the AF has not 
yet followed suit.  
These military-approved exercise interventions are centered on the concept of 
functional fitness, which is the idea of incorporating occupationally relevant exercise 
movements to optimize job-specific performance (Abt et al., 2010). Unlike traditional 
exercises which emphasize strengthening single muscle groups (e.g. bicep curls), 
functional fitness uses multi-planar movements that integrate balance and coordination 
along with strength. Some exercises are designed to simulate actual movement patterns 
necessary in a specific field of work, but done so in a controlled setting where soldiers 
are taught proper form and execution (Heinrich, Spencer, Fehl, & Carolos-Poston, 2012). 
Functional fitness also adopts contemporary aerobic exercises such as high-intensity 
interval training (HIIT), which has shown to be more effective in improving 
cardiovascular fitness than conventional steady-state running (Heinrich et al., 2012). This 
suggests that the principles of functional fitness should be an essential part of the 
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foundation on which future, AF-specific exercise programs should be based, and 
therefore were used to develop the novel exercise intervention in this study. 
Biomarkers of stress and performance 
Biomarkers have the potential to provide a connection between objective 
measures of physiology and performance. These markers may then become targets 
appropriate for physiological monitoring, stress mitigation, and performance 
enhancement.  
Stress is a key aspect of physiology known to affect human performance 
(Kirschbaum, 1996; Thomas, 2014). While acute stress may prove beneficial to 
performance (Greiwe, 1999; Zouhal, 2008), this benefit is temporary. Chronic and 
prolonged stressors result in performance detriment (Sapolsky, 2000; Bremner, 2006). 
Active duty military, especially members that have been deployed, face increased levels 
of stress that put them at risk for impaired performance (Booth-Kewley, 2010).  
As mentioned previously, nutritional supplements and exercise training regimens 
have the potential to improve cognitive and physical performance. Each of these types of 
interventions can also change a person’s biomarker profile (Chatard, 2002; Agha-
Alinejad, 2013; Kohanpour, 2013; Noreen, 2010; Aizawa, 2003, Markus, 2002). 
However, these associated changes in performance and physiology are not well-defined, 
particularly in the AF population. The better understood these connections are, the better 
they may be used for targets of performance monitoring and enhancement. This study 
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aims to clearly link aspects of physical and cognitive performance with empirical 
measures of blood-based biomarkers of stress and resilience.  
Due to the association of stress and performance, well-established biomarkers of 
stress will be measured over the course of these intervention programs. Perhaps equally 
important are measures of stress resilience markers, which have been shown to positively 
correlate with performance. Lastly, measures of neurotransmitters and cognitive signals 
have been linked with performance as well. For these reasons, the primary biomarkers 
chosen for examination in this study are: cortisol, dehydroepiandrosterone-sulfate 
(DHEA-S), norepinephrine (NE), neuropeptide-Y (NPY), and serotonin.  
Cortisol 
The glucocorticoid cortisol is a steroid hormone secreted by the adrenal cortex as 
the end-product of the Hypothalamic-Pituitary-Adrenal (HPA) Axis activation cascade in 
response to stress (Mason, 1968). Cortisol binds to glucocorticoid receptors (GRs) in the 
cytoplasm which then shuttle as a complex into the nucleus (Galigniana, 1998) to activate 
or repress transcription of genes that regulate metabolism (Newton, 2000). GRs are found 
ubiquitously throughout the body, resulting in pleiotropic effects upon cortisol release 
(Anacker, 2011). Cortisol primarily functions to prepare the body for future stress events 
via catabolism of stored energy resources. Cortisol increases in blood glucose 
concentrations by promoting glycogenolysis, lipolysis, and gluconeogenesis. Conversely, 
cortisol inhibits anabolic processes such as muscle growth and fat storage. Cortisol also 
functions to decrease inflammation and suppress the immune system by reducing 
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production of eicosanoids (prostaglandins) and inflammatory interleukins (Reichardt, 
2001).  
Cortisol exhibits diurnal fluctuation in humans, peaking in the hour after waking 
and decreasing throughout the day. Lower resting cortisol levels are associated with 
lower levels of stress. Exposure to a stress challenge, such as strenuous exercise (Davies, 
1973; Daly, 2005), public speaking (Bassett, 1987), or an academic exam (Maes, 1998) 
causes cortisol levels to increase significantly from baseline and peak approximately 20 
minutes after the event. The severity of the stress and the level of an individual’s stress 
resiliency will affect the extent of this increase (Morgan, 2002; Rimmele, et al. 2007).  
Cortisol is lipid soluble and readily crosses the blood-brain barrier (BBB). Very 
high cortisol levels released in response to stress are associated with performance 
detriment (Kirschbaum, 1996; Thomas, 2014). Similarly, studies show that chronic 
exposure to high cortisol levels may induce hippocampal atrophy (Sapolsky, 2000) and 
impair memory functioning (Bremner, 2006).  
Studies have shown that exercise training programs can reduce baseline cortisol 
levels (Staron, 1994; Kraemer, 1999; Chatard, 2002; Agha-Alinejad, 2013; Kohanpour, 
2013). Supplementation with fish oil has been shown to reduce salivary cortisol and total 
body fat mass (Noreen, 2010) as well as reducing cortisol levels in response to a mental 
stress test (Delarue, 2003).  
Due to its involvement in stress, performance, exercise, and nutrition, cortisol 
serves as a primary biomarker of interest in this study. 
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Dehydroepiandrosterone-sulfate (DHEA-S) 
Like cortisol, dehydroepiandrosterone (DHEA) is a steroid hormone released 
from the adrenal cortex as a result of HPA axis activation. DHEA is the most abundant 
hormone in humans (Maninger, 2009). Levels of DHEA peak in early adulthood and 
gradually decline with age (Orentreich, 1984). DHEA serves as a precursor molecule for 
testosterone and estrogen biosynthesis, but also applies its own effects as a neurosteroid 
(Starka, 2015). DHEA has no unique receptor, but binds to and activates N-methyl-D-
aspartate (NMDA) receptors, inhibits gamma-Aminobutyric acid (GABA)A, D2 
dopamine, and glycine receptors, contributing to overall excitatory activity (Perez-Neri, 
2008). DHEA exerts protective effects in the brain (Kaasik, 2001) and has been shown to 
induce neurogenesis in the rat hippocampus (Karishma, 2002).  
DHEA has a half-life of approximately 20 minutes. DHEA can be sulfated only in 
certain tissues (brain, lungs, liver, adrenals, kidneys, and intestines), but can be de-
sulfated in all tissues. The sulfated form of DHEA (DHEA-S) binds with greater affinity 
than DHEA to the carrier protein albumin. This binding slows its metabolic clearance, 
making DHEA-S levels relatively stable, lasting approximately 10 hours (Kamin, 2016). 
As a result, DHEA-S does not exhibit diurnal fluctuation (Starka, 2015). Circulating 
levels of DHEA-S are considered the body’s “DHEA reservoir” and changes in these 
levels are indicative of long term effects.  
Both DHEA and DHEA-S levels rise in response to a stressor (Taylor, 2012), 
however, these increases are associated with resilience to stress (Morgan, 2009). Petros 
2013 showed that salivary DHEA-S is highly correlated to positive aspects of 
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psychological health/resilience, whereas lower levels of DHEA-S have been associated 
with increased perceived stress (Lennartsson, 2013). In rats, DHEA has been shown to 
inhibit cortisone reductase, the enzyme which reduces cortisone to cortisol prior to its 
release (Tagawa, 2011). Due to these observations, DHEA and DHEA-S are considered 
to function as a counter-balance to cortisol.  
Aizawa, 2003 showed that resistance exercise training can increase DHEA-S 
levels. Nutrition may also impact levels of DHEA and DHEA-S. Calorie restriction 
paradigms are well-known to increase longevity and have been reported to slow the age-
related decline of serum DHEA-S in rhesus monkeys (Lane, 1997). 
DHEA-S levels may also be predictive of performance. Morgan, 2009 showed 
that higher baseline DHEA and DHEA-S levels sampled pre-task were positively 
correlated to underwater navigation scores in active duty military subjects.  
Norepinephrine (NE) 
Immediate responses to a stressor include autonomic nervous system (ANS) 
activation – the “fight-or-flight” response. ANS activation stimulates catecholamine 
(epinephrine [Epi], norepinephrine [NE], and dopamine) release from sympathetic fibers 
and the adrenal medulla. Epi binds to beta-adrenergic receptors in heart to increase heart 
rate. NE binds primarily to alpha adrenergic receptors. In the lungs and bronchi, binding 
results in airway dilation and increased oxygen uptake. In the trunk, binding results in 
splanchnic arterial vasoconstriction to decrease local circulation and increase systemic 
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arterial pressure and venous return. In the liver, binding results in glycogenolysis and 
increased blood glucose (for review, see Garcia-Sainz, 1995). 
Given that Epi and NE are involved in aspects of cardiovascular regulation such 
as control of breathing (Orem and Kubin, 2000) and glycogenolysis (Kreisman, 2001), it 
has been suggested that higher peak levels may confer physical performance benefit – the 
“sports adrenal medulla” theory (Kjær et al, 1986).  While Greiwe, 1999 supported this 
theory by showing increased catecholamine release in trained versus untrained 
individuals, other studies suggest exercise training causes a decrease in exercise-induced 
catecholamine release post training intervention, despite increases in VO2 Max scores 
(Friedlander et al., 1998, Winder et al., 1978, Winder et al., 1979). The effect of exercise 
training on resting catecholamine levels is also mixed (Zouhal, 2008). 
NE is also released centrally by the locus coeruleus to targets spanning the entire 
frontal lobe. It is involved in the control of attention and working memory (Clark, 1989; 
Smith, 1992; Coull, 1995). NE is related to cognitive performance, but these measures 
are dependent on an individual’s baseline arousal levels (Coull, 1999). Increases benefit 
lower arousal and impair higher arousal. Wang, 2013 bolstered these data by showing 
increases in NE improved cognitive performance, though excessive NE increases 
impaired performance.  
Of the catecholamines, NE was chosen for examination given its established 
association with both physical and cognitive performance. 
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Neuropeptide-Y (NPY) 
NPY is a 36 amino-acid neuropeptide. It is co-localized in the adrenal medulla 
and sympathetic fibers with NE and similarly released in response to ANS activation 
(Schutz, 1998). It is also produced and released throughout the central nervous system 
(CNS). No primary source of central NPY is known, but it is highly expressed in the 
hypothalamus, amygdala, hippocampus, septum, and neocortex (Michel, et. al 1998; 
Kask, 2002). NPY binds mainly to the Y family of receptors (Y1, 2, 4, 5, and 6) which 
are inhibitory G-coupled receptors. NPY is widely involved in energy homeostasis, 
promoting feeding behavior and fat storage (Loh, 2015). Centrally, NPY acts a 
vasodilator and induces anxiolytic effects in animal models (Heilig, 1989; Heilig, 1992; 
Sajdyk, 2004). Peripherally, NPY regulates blood pressure by acting directly as a 
vasoconstrictor and by modulating catecholamine release (Westfall, 2004; Holwerda, 
2015). Further studies associate NPY with stress resilience in humans (Rassmusen, 2000; 
Morgan, 2003). Notably, NPY does not cross the BBB. Plasma NPY levels are not 
correlated with cerebrospinal fluid (CSF) NPY levels and do not exhibit diurnal 
fluctuation (Baker, 2013).  
Though NPY does not cross the BBB, peripheral levels have been correlated with 
performance under stress. Morgan, 2000 showed that US Army soldiers released NPY in 
conjunction with cortisol and NE, but those who had higher levels of NPY release had 
better performance scores under simulated enemy capture-and-interrogation and fewer 
symptoms of dissociation, a product of high stress. This study was replicated in US Navy 
personnel and found concurring results (Morgan 2002). Lieberman, 2016 also showed 
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that in US Army soldiers, performance under extreme stress was positively associated 
with higher levels of NPY. 
Serotonin  
Serotonin (5-hydroxytryptamine or 5-HT) is a monoamine converted from the 
amino-acid L-tryptophan by the enzyme tryptophan hydroxylase. It is released centrally 
by the Raphe Nuclei, hypothalamus, and cerebellum (Simansky, 1996). Peripherally, it is 
released by the enterochromaffin cells of the gut endothelium and stored in circulating 
platelets (Erspamer, 1954). Serotonin binds to the 5-HT family of receptors which have a 
wide range of function. Most are G-coupled receptors - one is a ligand-gated ion channel 
- and most are excitatory. Serotonin does not cross the BBB but its precursor L-
tryptophan does (Birdsall, 1998). Serotonin is involved in mood, memory, the sleep/wake 
cycle, appetite regulation, gut motility, energy homeostasis, control of breathing, and 
vascular tone (Rapport, 1948; Young, 1985; Altman, 1988; Risch, 1992; Bach, 1993; 
Jouvet, 1999; Kereveur, 2000).  
Stress increases serotonergic activity in the brain (Joseph, 1983). Prolonged stress 
may exhaust serotonin availability over time, resulting in worsened cognitive 
performance as resources decline (Markus 1998; Markus, 1999). While serotonin cannot 
cross the BBB, AFRL investigators have argued that peripheral serotonin may be 
associated with cognitive performance. Data from Shia et al. 2015 shows that subjects 
performing a treadmill task who displayed higher levels of serotonin pre- versus post-task 
showed decreased performance, while subjects who displayed levels of serotonin that 
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increased pre- to post-task showed sustained performance (Shia et al., 2015). This 
evidence supports the idea that serotonin may be involved in central resource availability. 
Exercise training has been shown to increase serotonin levels in the rat brain, 
providing a potential mechanistic cause for the well-known antidepressant effects of 
exercise (Dey, 1992). Nutritional deficits that cause lowered tryptophan levels result in 
depressed mood (Young, 1985). Supplementation with alpha-lactalbumin, a precursor of 
serotonin, has been shown to increase cognitive performance in subjects particularly 
vulnerable to stress (Markus, 2002). Though there is less evidence for serotonin’s 
associations with performance compared to the previous biomarkers, we propose that it 
warrants further investigation. 
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SPECIFIC AIMS 
This study aims to evaluate the effects of a unique nutritional supplement 
combined with requisite physical training on biomarkers of stress, resilience, and 
vigilance. Biomarker levels will be associated with cognitive and physical performance 
measures. Understanding these relationships will help identify target biomarkers for the 
development of future interventions aimed at cognitive and physical performance 
enhancement. We hypothesize that the nutritional supplement and physical training 
interventions will decrease biomarkers associated with stress and/or increase markers of 
resilience, arousal, and vigilance, and these changes will be linked with performance 
improvement.  
Aim 1a:  
Assess the changes in biomarkers of stress, resilience, and vigilance over the 
course of the exercise intervention. We hypothesize that both groups will exhibit lower 
stress markers and/or higher resilience and vigilance marker levels post-intervention 
compared to pre-intervention. 
Aim 1b:  
Assess the changes in biomarkers of stress, resilience, and vigilance over the 
course of the nutritional intervention. We hypothesize that the experimental supplement 
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group will exhibit lower stress markers and/or higher resilience and vigilance markers 
pre-to post-intervention as compared to control. 
Aim 2:  
Establish relationships between cognitive and physical performance and 
peripheral blood biomarkers of stress, resilience, arousal, and vigilance. We hypothesize 
that higher performance will be associated with lower stress and/or higher resilience and 
vigilance biomarker levels. 
  
15 
 
 
METHODS  
Experimental Design and Sample Size 
 A 2x1, double-blind, placebo-controlled design was implemented. Participants 
were assigned to one of two groups – Experimental or Placebo – and underwent the same 
exercise training intervention. Due to space and personnel limitations, the study was 
divided into six cohorts of approximately 25 participants per cohort. Participants were 
over-recruited (max 35 per cohort) to mitigate the effects of attrition. Within each cohort, 
participants received the same nutritional supplement (experimental or placebo) and the 
groups were seasonally balanced (see Table 1). 
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Table 1. Study design. The two groups were divided into six cohorts and seasonally 
balanced. Both subjects and experimenters were blind to this design.
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Season Year 1 Year 2 
Winter 
(Jan-Apr) 
Cohort 1 
(experimental) 
Cohort 4 
(placebo) 
Summer 
(May-Aug) 
Cohort 2 
(placebo) 
Cohort 5 
(experimental) 
Fall 
(Sep-Dec) 
Cohort 3 
(experimental) 
Cohort 6 
(placebo) 
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Participants 
Active duty Air Force men and women between the ages of 18-45 were recruited. 
To determine eligibility, the demographics and health screening questionnaire (See 
Surveys/Questionnaires) were reviewed by the medical monitor prior to any participant 
taking part in experimental procedures. Airmen were excluded from participating in this 
study if: 
- They were not active duty 
- They were unable/unwilling to commit to participating in this study for 14 
consecutive weeks 
- They were younger than 18, or older than 45, years of age 
- They were on a medical or pregnancy profile 
- They were taking prescribed blood pressure medication 
- They were unwilling to stop the use of certain herbal dietary supplements, 
performance supplements, or any other substance that contains ingredients that 
could affect cardiovascular response with exercise. 
- They were suffering from a musculoskeletal injury that would limit their ability to 
engage in heavy resistance and/or aerobic exercise. 
- They were suffering from cardiovascular or respiratory disease that would limit 
their ability to engage in heavy resistance and/or aerobic exercise. 
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Duration 
Data collection lasted two years. The total duration of participation for each 
subject in this study was 14 weeks. The testing and training schedule is provided in 
Figure 1. In this schedule, weeks 1 and 14 were allocated to baseline and post-test 
performance assessments, and weeks 2 through 13 were allocated to participation in the 
exercise training and nutritional interventions 
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Figure 1. Exercise intervention testing and training schedule.
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Week 1 – Baseline Testing
Mon (2 hrs.) Wed (2 hrs.) Fri (2 hrs.)
Blood Draw/Physical Test Battery (Part 1) Physical Test Battery (Part 2) Cog Test/VO2max/Blood Draws
Weeks 2, 6, & 10
Mon (1 hr.) Tues (1 hr.) Wed (1 hr.) Thurs. (1 hr.) Fri (1 hr.)
Total Body Resistance 
Circuit 1
Active Recovery & Light 
Cardio 1
Total Body Resistance
Circuit 2
Active Recovery & Light 
Cardio 2
Intense Cardio Circuit 1 
(Bike, Run, Elliptical)
Week 14 – Post-Test
Mon (2 hrs.) Wed (1.5 hrs.) Fri (1.5 hrs.)
Blood Draw/Physical Test Battery (Part 1) Physical Test Battery (Part 2) Cog Test/VO2max/Blood Draws
Individual Participant Testing & Training Schedule
Exercise Intervention
Testing
Testing
Weeks 3, 7 , & 11
Mon (1 hr.) Tues (1 hr.) Wed (1 hr.) Thurs. (1 hr.) Fri (1 hr.)
Total Body Resistance 
Circuit 3
Active Recovery & Light 
Cardio 3
Total Body Resistance 
Circuit 4
Active Recovery & Light 
Cardio 4
Intense Cardio Circuit 2 
(Bike, Run, Elliptical)
Weeks 4, 8, & 12
Mon (1 hr.) Tues (1 hr.) Wed (1 hr.) Thurs. (1 hr.) Fri (1 hr.)
Total Body Resistance 
Circuit 5
Active Recovery & Light 
Cardio 5
Total Body Resistance 
Circuit 6
Active Recovery & Light 
Cardio 6
Intense Cardio Circuit 3 
(Bike, Run, Elliptical)
Weeks 5, 9 & 13
Mon (1 hr.) Tues (1 hr.) Wed (1 hr.) Thurs. (1 hr.) Fri (1 hr.)
Total Body Resistance 
Circuit 7
Active Recovery & Light 
Cardio 7
Total Body Resistance 
Circuit 8
Active Recovery & Light 
Cardio 8
Intense Cardio Circuit 4 
(Bike, Run, Elliptical)
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Nutritional Supplements 
Supplement Description 
Abbott Nutrition prepared two liquid nutritional supplements for examination in 
this study. The first was the experimental supplement, from here on referred to as the 
high nutrient supplement. This supplement was a tailored combination of active nutrients 
independently shown to be effective for improving cognitive function (e.g., 
docosahexaenoic acid [DHA] and lutein), and promoting muscle recovery (e.g., calcium 
hydroxy-methylbutyrate [Ca-HMB] and protein). The high nutrient supplement had a 
caloric content of no more than 270 calories (Cal) per 8 oz. serving. The second 
supplement was a placebo, from here on referred to as the low nutrient supplement. This 
supplement was comprised of marginal amounts of protein, fat, carbohydrates, and 
minerals in order to provide some of the basic nutrition necessary for exercise. The low 
nutrient supplement had a caloric content of no more than 110 Cal per 8 oz. serving.  
Supplement Dosage Schedule 
Throughout the exercise intervention (Weeks 2 to 13), participants ingested two 8 
oz. servings of either the high or low nutrient supplement (dependent upon group 
assignment) per day. During the work week (Monday through Friday), ingestion of each 
serving was be supervised by research staff. It was recommended that ingestion occur a 
few minutes prior to and immediately following each exercise session, but some 
participants chose to ingest their servings all prior to exercise, all post exercise, or as a 
meal replacement earlier in the day (also supervised). On the weekends (Saturday and 
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Sunday), research staff provided participants with a total of 4 servings to take home, and 
asked that participants take the supplement along with breakfast and lunch (See Table 2 
for a dosage schedule). In order to confirm compliance with weekend ingestion, 
participants were required to return the empty bottles to the researchers on each following 
Monday.  
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Table 2. Weekly nutritional supplement dosage schedule for all participants. 
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Weekly Nutritional Supplement Dosage Schedule
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
Supervised 
Ingestion by 
Research Staff
Yes Yes Yes Yes Yes No No
Ingestion Timing 8 oz. prior to 
exercise; 8 oz. 
post-exercise
8 oz. prior to 
exercise; 8 oz. 
post-exercise
8 oz. prior to 
exercise; 8 oz. 
post-exercise
8 oz. prior to 
exercise; 8 oz. 
post-exercise
8 oz. prior to 
exercise; 8 oz. 
post-exercise
8 oz. with 
breakfast; 8 oz. 
with lunch
8 oz. with 
breakfast; 8 oz. 
with lunch
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Biomarkers 
Blood Sample Collection 
To determine the changes in biomarker levels, peripheral blood samples were 
collected throughout the course of this study. Samples were collected by AFRL medical 
technicians and certified phlebotomists via antecubital venipuncture. To appropriately 
obtain and preserve the biomarkers in each sample, serum collection tubes (red-top) and 
plasma collection tubes with K2 EDTA (purple-top) were used (BD Vacutainer). 
Immediately following each draw, samples will be allowed to clot for 30-60 minutes at 
room temperature. Two protease inhibitors, DPP-IV and Aprotinin (Sigma), were added 
immediately to the purple-top tubes specifically for preservation of NPY (Frerker, 2007). 
A protease inhibitor cocktail (Sigma) were added to the serum aliquot microtubes. The 
samples were centrifuged at 3500×g for 15 min at 4 °C, pipetted into the appropriate 
serum and plasma aliquots, and stored in a -80 degrees centigrade (C) freezer until ready 
for analysis. These samples were de-identified by labeling using a subject number, draw 
number, and date. Multiple aliquots of each sample were made to avoid freeze-thaw 
cycles and resulting sample degradation. 
Blood Collection Scheme 
At total of 12 samples were obtained throughout the experiment. Blood was 
drawn during pre-testing and post-testing (Weeks 1 and 14, respectively) to evaluate the 
effects of the nutritional and exercise interventions on the biomarkers of stress and 
resilience. To evaluate the effects of the interventions on resting biomarker levels and 
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biomarker release under stress, draws were scheduled around the VO2 Max tests. The 
baseline draw (low stress) was performed at rest prior to the VO2 Max test, and two 
draws (high stress) were performed after the VO2 Max test - one immediately following 
and one 20 minutes following. These allowed for collection of biomarkers that release 
quickly in response to stress (NE, NPY, serotonin) and for those that have a delayed 
release (cortisol, DHEA-S). To further evaluate the effects of the interventions over time, 
three additional low stress draws were performed during the intervention on Weeks 4, 7, 
and 10 prior to exercise (at rest) on Fridays. The blood draw schedule for each participant 
and the specific biomarkers assessed from each draw is summarized in Table 3. 
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Table 3. Blood draw schedule. Blood was drawn three times during pre-testing and post-
testing, and three times during the interventions for a total of nine draws. Blood was 
drawn under low and high stress conditions. 
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 Pre-Testing Blood Draws Mid Training Blood Draws Post-Testing Blood Draws 
Study 
Week 1 4 7 10 14 
Draw 
Timing 
Test Day 1 Test Day 1 Test Day 1 
Pre-
Exercise 
(Friday) 
Pre-
Exercise 
(Friday) 
Pre-
Exercise 
(Friday) 
Test Day 1 Test Day 1 Test Day 1 
Pre-VO2 
Max  
0 min          
Post-VO2 
Max  
20 min        
Post-VO2 
Max  
Pre-VO2 
Max  
0 min          
Post-VO2 
Max  
20 min        
Post-VO2 
Max  
Biomarkers 
Analyzed 
Cortisol    
DHEA-S         
NE               
NPY       
Serotonin      
NE               
NPY       
Serotonin      
Cortisol    
DHEA-S 
Cortisol    
DHEA-S         
NE               
NPY       
Serotonin      
Cortisol    
DHEA-S         
NE               
NPY       
Serotonin      
Cortisol    
DHEA-S         
NE               
NPY       
Serotonin      
Cortisol    
DHEA-S         
NE               
NPY       
Serotonin      
NE               
NPY       
Serotonin      
Cortisol    
DHEA-S 
 
30 
 
 
Biomarker Assay Procedure 
Biomarkers of stress and resilience were evaluated via enzyme-linked 
immunosorbent assay (ELISA) by trained laboratory personnel. These biomarkers 
included: cortisol, dehydroepiandrosterone sulfate (DHEA-S), norepinephrine (NE), 
neuropeptide Y (NPY), and serotonin. To maintain sample integrity, assays were 
performed after the conclusion of each of the six cohorts.  
All ELISA kits used were previously validated in human participants within the 
lab. Assays were strictly executed according to the instructions set forth in each kit. To 
minimize the effect of natural variation in each kit, products of the same lot were 
purchased for each cohort, standard curves were generated for each plate, and samples 
were randomly assigned to the plates. Each sample was run in duplicate and averaged. 
Samples that fell off the standard curve or had high (>30%) variation between duplicates 
were re-assayed. Plates were read using the Spectromax 180 Spectrophotometer and the 
resulting data were processed with the Softmax 7.0 software. 
Cognitive Testing 
Cognitive Function Battery (CFB) 
To assess cognitive performance changes, participants performed the CFB, which 
comprises a series of computer-based cognitive performance tests using E-prime® 
software scripts. Each test in this battery reflects custom instantiations of well-validated 
cognitive performance tests, such as the digit span test for working memory (Baddeley & 
Hitch, 1974). These tests were administered at rest during baseline and post-testing 
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(Weeks 1 and 14). The list of tests and the cognitive functions they assess is summarized 
in Table 4.  
Symbol-Digit Modalities Test (SDMT) 
The SDMT is a single test designed to assess working memory. Unlike the CFB, 
this test was administered using pencil and paper and occurred immediately following the 
VO2 Max test during both pre and post-testing. The administration of this test was 
designed to yield a measurement of cognitive performance under peak physical stress 
compared to the CFB which was administered at rest. 
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Table 4. Descriptions of the computer-based cognitive tests included in the Illinois 
Cognitive Function Battery (ICFB). 
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Illinois Cognitive Function Battery
Test Name Cog. Function 
Assessed
Duration (min)
Number Set Fluid Intelligence 7
Letter Set Fluid Intelligence 10
Digit Span Working Memory 10
Rotational Span Working Memory 11
Decision-Making Executive Function 20
Keeping Track Executive Function 16
Paired Associates Episodic Memory 5
Immediate Free 
Recall (pictures)
Episodic Memory 8
Delayed pics Recall Episodic Memory 3
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Physical Testing 
Baseline and Post-Testing Battery 
A comprehensive physical test battery (summarized in Table 5) was developed by 
AFRL researchers to examine a broad set of physical performance characteristics deemed 
relevant for AF physical training and field operations. These tests were administered 
during baseline and post-testing (Weeks 1 and 14). 
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Table 5. Description of the physical performance tests included in the physical 
performance test battery that were administered at baseline and post-testing.
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Physical Performance 
Test Test Description 
Performance Dimension 
Assessed 
Body Weight Stand still atop a high-performance electronic scale.  Gross body mass 
Height Assessed using a tape measure in accordance with USAF standards. Vertical height 
Resting Blood Pressure 
(BP) 
The amount of pressure in the arteries during a 
heartbeat (systolic/top number) over the 
pressure in the arteries when the heart chambers 
are refilling (diastolic/bottom number) – a 
series of three readings taken at rest either 
manually or using an electronic BP monitor. 
Normal: Approximately 
120/80 mmHg 
Resting Heart Rate 
(HR) 
Number of heart beats per minute (bpm) at rest 
as assessed using an electronic BP monitor. 
Used to predict maximal and 
exercise target zones; Normal 
adult range: 60-100 bpm 
Body Fat Percentage 
(%) 
DEXA - Determines an individual’s overall and 
segmented body composition using X-ray 
technology. 
Healthy body fat percentages 
for men ages 20-40: 8% to 
21%; women ages 20 – 40: 
21% to 32% 
Lean Muscle Mass 
(lbs.) 
DEXA - Determines an individual’s overall and 
segmented body composition using X-ray 
technology. 
Total muscle mass gained/lost 
Push-ups 
Administered according to USAF PT test 
standards. Properly complete as many push-ups 
as possible within 1-minute.  
Strength and endurance of 
upper body and torso muscle 
groups. 
Sit-ups 
Administered according to USAF PT test 
standards. Properly complete as many sit-ups as 
possible within 1-minute.  
Strength and endurance of 
torso muscle groups. 
Abdominal 
Circumference 
Assessed via hip circumference using a tape 
measure in accordance with USAF standards. 
Maximal length around your 
hips; Reflective of abdominal 
fat composition measured in 
inches. 
1.5 mile Run Run 1.5 miles as fast as possible. Cardiovascular fitness (time) 
VO2 max 
Bruce Protocol – Walk/run on a treadmill with 
incremental increases in speed and incline to 
exhaustion while oxygen consumption was 
measured. 
Maximal aerobic capacity ; 
Indicator of cardiorespiratory 
fitness; Average values: 35-46 
ml/kg/min for men 18-45 years 
of age; 29-39 ml/kg/min for 
women 18-45 years of age 
Wingate Cycle 
Ergometer Test 
(Upper and Lower 
Body) 
Bicycle pedal (or arm crank) as fast as possible 
against a fixed resistance for 30 seconds. 
Maximum and average peak 
anaerobic power 
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Vertical Jump 
The best of 3 jumps measured using the 
standard Vertec procedures from a 2 foot static 
position. 
Explosive lower extremity 
power 
Male avg.= 16-20 in 
Female avg. = 12-16 in 
Standing Long Jump The best of 3 longitudinal jumps from a 2-foot static position. 
Explosive lower extremity 
power 
Male avg. = 7’3” – 7’ 6.5” 
Female avg. = 5’1” – 6’0 
Sled Push and 
Backpedal 
Push (15 yd.) and pull (15 yd.) a 140lb sled 2x 
for a total of 60 yds. without stopping. 
Total body anaerobic power 
and endurance (time) 
Alternate Pull-up Test As many pull-ups as possible until exhaustion in a modified position. 
Upper body muscular 
endurance (reps) 
300 yd. Sand Bag 
Carry 
Run (30 yd.) with a 40 lb. sand bag, drop the 
bag; Run (30 yd.). Repeat 6x. 
Total body endurance & speed 
(time) 
Supine Bridge 
Isometric hold in a supine bridge position. Test 
ends when the participant can no longer hold 
the bridge. 
Trunk muscular endurance and 
control (time) 
Lateral Bridge Isometric hold in a lateral plank position for up to 30 sec. 
Endurance strength of trunk 
lateral flexor (Grade 1-5). 
Illinois Agility Test Complete a weaving running course in the shortest possible time. Speed and Agility (time) 
Y-Balance Test Multi-planar movement assessment to test dynamic balance. 
Functional balance (summative 
score of 3 dimensions for 
lower and upper body) 
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12 Week Training Intervention 
All participants underwent a novel, 12-week exercise training intervention. 
Participants were asked to attend 5 exercise sessions per week (Monday through Friday), 
with each session lasting approximately 1 hour. Participants with less than 80% 
attendance were excluded from data analysis. All exercise sessions included a warm-up, 
focal exercise routine, and a cool-down. These routines were developed by AFRL 
researchers which includes two certified and licensed Athletic Trainers with expertise in 
injury prevention and exercise rehabilitation. All participants were provided with a heart 
rate monitor to be worn during each exercise session in order to view and adjust their 
personal exercise intensity levels and rest periods.  
Individual exercise routines focused on improving upper- and lower-body 
strength (Mondays and Wednesdays), active recovery, flexibility, and core strength 
(Tuesdays and Thursdays), and cardiovascular endurance training/HIIT (Fridays) (see 
Figure 1). Participants were guided on proper form for each exercise, and all exercise 
sessions were supervised by at least one member of the research staff. 
Surveys/Questionnaires 
Participants were asked to fill out surveys to obtain demographic information, 
assess subjective stress and resilience levels, and to determine eating and exercise habits. 
Well-validated surveys, especially those validated within military populations, were 
chosen. All surveys were taken during baseline and post-testing with the exception of the 
39 
 
 
Daily Nutritional Intake, which was administered over the course of the exercise 
intervention period. These surveys and their descriptions are listed below. 
Demographic & Medical Screening Questionnaire Profile 
This questionnaire was used to obtain basic demographic information about each 
participant, such as his/her military rank, education level, age, and gender. It was used by 
the medical monitor to screen participants for medical issues that may preclude 
eligibility, including the use of confounding prescription drugs or disease.  
Life Stress Questionnaire-modified (LSQ) 
The LSQ measures chronic life stressors (Lustman, Sowa, & Day, 1991). 
Wheatley (2009) condensed the LSQ to include only questions that operationalized 
chronic stress. The abridged version was used in this study. This questionnaire was used 
as a ground truth assessment, comparing participants’ subjective stress levels with their 
stress biomarker levels. It was also used to validate outlying data. For example, 
biomarker data showing high stress levels at rest may have been caused by a recent 
deployment and not due to an error in lab work. 
Brief Resilience Scale (BRS) 
The BRS was designed to test an individual’s ability to recover from stress 
(Windle, Bennett, & Noyes, 2011). The strategy in creating the scale was to use as few 
items as necessary to develop a reliable scale to assess resilience. There are an equal 
number of positive and negatively worded items to decrease the likelihood of positive 
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response bias (Smith et al., 2008). This scale was also used as a ground truth assessment, 
comparing participants’ subjective resilience levels with their resilience biomarker levels.   
Daily Nutritional Intake (DNI) 
This 5-minute survey was developed by AFRL researchers in order to periodically 
assess participants’ dietary intake, as well as sleeping habits, alcohol consumption, and 
nicotine use. Participants took this survey electronically once a week on varying days. 
While we expect that the nutrients contained in the supplement will enhance 
performance, participants may not experience this enhancement if they already consume 
a diet that contains the active ingredients. For example, DHA supplementation may not 
show a positive cognitive effect in participants who already consume a diet high in fish. 
Additionally, though each subject was advised to have at least 6 hours of sleep prior to 
testing, subjects were not excluded from testing based on their sleep habits. Inadequate 
sleep may increase cortisol levels and effect performance (Leproult, 1997). Physiological 
data was compared to the DNI to explain possible outliers or discrepancies. 
  
41 
 
 
RESULTS 
A total of 130 subjects (58 in the High Nutrient Group and 72 in the Low Nutrient 
Group) completed the 12-week nutritional and exercise intervention with at least 80% 
workout attendance. Additional descriptive statistics for our subject population is given in 
Table 6.  
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Table 6. Descriptive characteristics of subjects (n= 130). On average, both groups had 
comparable physical attributes at baseline.  
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 High Nutrient Group Low Nutrient Group 
Total Subjects 58 72 
Males 45 51 
Females 13 21 
Mean Age (yr) 30.3  30.1  
Mean VO2 Max (ml/kg/min) 43.6  45.2  
Mean Lean Muscle Mass (lbs) 124.0  123.7 
Mean Body Fat (%) 27.9 28.9 
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Statistical Analysis – Aim 1 
Assessment of biomarker changes over the course of the intervention within (Aim 
1a) and between (Aim 1b) the two groups was performed with the repeated measures 
analysis of variance (ANOVA) statistical test. A repeated measures ANOVA was run for 
each of the five biomarker variables under each type of stress condition - low stress 
(resting levels pre-VO2 Max), high stress (peak levels post-VO2 Max), and stress change 
(high stress minus low stress) with time point as the repeated measure.  Age and gender 
were covaried for DHEA-S analysis, and time of day was covaried for cortisol analysis. 
Outlying data were evaluated for exclusion by cross-referencing the questionnaires and 
demographic information, as previously described. IBM SPSS Statistics version 25 was 
used for all primary analyses. SAS version 9.4 was used for post-hoc analyses. A level of 
significance alpha=0.05 was used throughout. 
The results of the overall F-test for the within-subjects effects are given in Table 
7, and the results for the between-subjects effects are given in Table 8. To account for 
any data lacking sphericity, the Greenhouse-Geisser statistic was used. P-values that are 
less than 0.05 indicate evidence of a significant difference between at least two of the 
time points.  Variables where a significant difference was detected are indicated in 
boldface. Bonferroni’s post hoc multiple comparison procedure was performed for each 
of the significant models with more than two time points (Table 9).  This procedure 
adjusts the P-values of the pair-wise comparisons to control for a potentially inflated type 
I error that can result from running multiple tests.  Therefore, the type I error rate for each 
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of the repeated measures ANOVAs is held constant at alpha=0.05. Plots of the 
statistically significant comparisons are given in Figures 2-6.  
Statistical Analysis – Aim 2 
Bivariate correlations were performed to assess the relationships between 
biomarker levels and physical and cognitive performance scores. Partial correlations were 
performed for cortisol to control for time of day and DHEA-S to control for age and 
gender. The Pearson correlation coefficients are given in Tables 10-39. Red shaded cells 
indicate positive correlations and blue shaded cells indicate negative correlations. Darker 
shading represents stronger association. Shading begins at the Pearson correlation critical 
value for n=100 at alpha=.05.  
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Table 7: P-values for the overall F-tests for the Within-Subjects Effects. Highlighted 
values denote significance. High stress and stress change cortisol and low stress NPY 
levels decreased.
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Response Variable P-value 
Cortisol (low stress) 0.138 
Cortisol (high stress) 0.030 
Cortisol (stress change) 0.002 
DHEA-S (low stress) 0.749 
DHEA-S (high stress) 0.744 
DHEA-S (stress change) 0.918 
NE (low stress) 0.608 
NE (high stress) 0.657 
NE (stress change) 0.532 
NPY (low stress) 0.010 
NPY (high stress) 0.080 
NPY (stress change) 0.060 
Serotonin (low stress) 0.340 
Serotonin (high stress) 0.424 
Serotonin (stress change) 0.217 
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Table 8: P-values for the overall F-tests for the Between-Subjects Effects. Highlighted 
values denote significance. High Stress NE levels decreased in the High Nutrient 
(experimental) group.
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Response Variable P-value 
Cortisol (low stress) 0.842 
Cortisol (high stress) 0.807 
Cortisol (stress change) 0.672 
DHEA-S (low stress) 0.851 
DHEA-S (high stress) 0.670 
DHEA-S (stress change) 0.747 
NE (low stress) 0.243 
NE (high stress) 0.050 
NE (stress change) 0.069 
NPY (low stress) 0.819 
NPY (high stress) 0.654 
NPY (stress change) 0.643 
Serotonin (low stress) 0.984 
Serotonin (high stress) 0.323 
Serotonin (stress change) 0.545 
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Table 9: Results of Bonferroni’s multiple comparison procedure for Low Stress NPY. 
The most relevant points of comparison (Baseline/Week 1 vs all other time points) were 
not significantly different.
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Least Squares Means Estimates 
Adjustment for Multiplicity: Bonferroni 
Effect Label Estimate 
Standard 
Error DF t Value Pr > |t| Adj P Alpha Lower Upper 
Adj 
Lower 
Adj 
Upper 
Time Week   
1 vs 4 
-1.8044 0.7725 128.7 -2.34 0.0210 0.0842 0.05 -3.3327 -0.2760 -3.7612 0.1525 
Time Week   
1 vs 7 
-0.3863 0.7888 223.8 -0.49 0.6248 1.0000 0.05 -1.9408 1.1682 -2.3726 1.6000 
Time Week   
1 vs 10 
-0.5856 1.0218 238.7 -0.57 0.5671 1.0000 0.05 -2.5985 1.4273 -3.1572 1.9860 
Time Week   
1 vs 14 
1.2927 0.7706 259.2 1.68 0.0946 0.3786 0.05 -0.2247 2.8101 -0.6455 3.2309 
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Figure 2. Low Stress NPY levels pre- to post-intervention. The overall decreases in low 
stress/resting NPY levels pre- to post-intervention were not significant. 
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Figure 3. High Stress NE levels pre- to post-intervention. Average high stress condition 
NE levels decreased significantly in the High Nutrient Group (experimental) compared to 
the Low Nutrient Group (control) pre- to post-intervention. 
   
55 
 
 
 
  
Average High Stress NE levels (ng/mL)  
                             Testing Week  
   
 S
er
um
 N
E 
(n
g/
m
L)
  
             1                                       14 
56 
 
 
Figure 4. High Stress cortisol levels pre- to post-intervention. Average High Stress 
condition cortisol levels decreased significantly in both groups pre- to post-intervention. 
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Figure 5. Cortisol level change from baseline to peak stress pre- to-post- intervention. 
Average cortisol level change from Low Stress to High Stress conditions decreased 
significantly in both groups pre- to post-intervention. 
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Table 10. Pearson Correlation Results. Cortisol levels compared to Anthropometric and 
Cardiac Physical Performance measures. Red shaded cells indicate positive correlations 
and blue shaded cells indicate negative correlations. Darker shading represents stronger 
association. Pre-testing peak cortisol was negatively correlated with heart rate.
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  CORTISOL 
   
CORT 
BD1 
CORT 
BD7 
CORT 
BD3 
CORT 
BD9 
CORT 
BD3 - 
BD1 
CORT 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
ANTHRO-
POMETRICS 
WeightB -0.074 -0.071 -0.001 -0.135 0.059 -0.046 
WeightP -0.079 -0.060 0.018 -0.111 0.061 -0.072 
BodyFatB 0.002 -0.204 -0.174 -0.092 -0.164 -0.176 
BodyFatP 0.024 -0.185 -0.146 -0.095 -0.164 -0.208 
PreAbCir -0.164 -0.089 -0.081 -0.165 0.030 -0.143 
PostAbCir -0.129 -0.116 -0.045 -0.138 0.037 -0.148 
LMMB -0.074 0.055 0.099 -0.065 0.137 0.054 
LMMP -0.089 0.042 0.092 -0.058 0.134 0.042 
CARDIAC 
PreRestingHR -0.083 0.110 -0.237 0.174 -0.242 -0.141 
PostRestingHR -0.005 0.103 -0.207 0.173 -0.215 0.062 
PreSystolic -0.032 0.024 0.086 0.051 -0.004 -0.035 
PostSystolic -0.140 0.204 0.111 0.015 0.087 -0.057 
PreDiastolic -0.062 0.172 0.078 0.126 0.013 -0.189 
PostDiastolic  -0.119 0.038 -0.061 0.093 -0.047 -0.101 
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Table 11. Pearson Correlation Results. Cortisol levels compared to Agility, Aerobic 
Power, Muscle Endurance, and Core Endurance Physical Performance measures. Red 
shaded cells indicate positive correlations and blue shaded cells indicate negative 
correlations. Darker shading represents stronger association. Pre-testing high stress 
cortisol and stress-induced cortisol release was positively correlated with nearly all 
aspects of pre-testing performance scores and some post-testing performance scores, and 
negatively correlated with Agility. Agility is scored as time to course completion, 
therefore a lower number indicates a better score. Post-testing high stress and stress 
change cortisol were also positively correlated with some aspects of pre- and post-testing 
performance scores. 
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    CORTISOL 
    CORT BD1 
CORT 
BD7 
CORT 
BD3 
CORT 
BD9 
CORT 
BD3 - 
BD1 
CORT 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
AGILITY 
PreAgility -0.068 -0.192 -0.364 -0.174 -0.362 -0.144 
PostAgility -0.038 -0.231 -0.315 -0.188 -0.317 -0.130 
AEROBIC POWER 
VO2MaxB -0.006 0.280 0.211 0.100 0.204 0.093 
VO2MaxP 0.005 0.236 0.301 0.269 0.215 0.165 
MUSCLE 
ENDURANCE 
PrePushups 0.081 0.215 0.297 0.077 0.224 0.133 
PostPushups 0.032 0.165 0.274 0.026 0.255 0.129 
PreModPullUp -0.141 0.123 0.150 0.038 0.249 0.195 
PostModPullUp -0.120 0.148 0.156 0.036 0.244 0.192 
CORE 
ENDURANCE 
PreSitups 0.117 0.300 0.377 0.195 0.187 0.138 
PostSitups 0.093 0.349 0.353 0.173 0.276 0.168 
PreSupBridgeR 0.223 0.272 0.129 0.255 0.146 0.280 
PostSupBridgeR 0.059 0.156 0.041 0.104 0.113 0.147 
PreSupBridgeL 0.170 0.256 0.262 0.259 0.232 0.284 
PostSupBridgeL 0.087 0.157 0.090 0.132 0.134 0.193 
PreSupBridgeRL 0.207 0.276 0.202 0.269 0.195 0.291 
PostSupBridgeRL 0.075 0.160 0.067 0.120 0.127 0.175 
PreLatBridgeR 0.119 0.152 0.197 0.149 0.209 0.242 
PostLatBridgeR 0.142 0.119 0.138 0.122 0.114 0.225 
PreLatBridgeL 0.162 0.184 0.243 0.150 0.210 0.285 
PostLatBridgeL 0.062 0.115 0.044 0.058 0.107 0.157 
PreLatBridgeRL 0.145 0.174 0.227 0.155 0.218 0.275 
PostLatBridgeRL 0.105 0.120 0.094 0.092 0.114 0.197 
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Table 12. Pearson Correlation Results. Cortisol levels compared to Anaerobic Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. Pre-
testing high stress cortisol and stress-induced cortisol release was positively correlated 
with Long Jump and Wingate pre-testing performance scores, and negatively correlated 
with Rope Pull and Sled Push/Pull pre-testing performance scores. Rope Pull and Sled 
Push/Pull are scored as time to task completion, therefore a lower number indicates a 
better score.
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    CORTISOL 
    CORT BD1 
CORT 
BD7 
CORT 
BD3 
CORT 
BD9 
CORT 
BD3 - 
BD1 
CORT 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
ANAEROBIC 
POWER 
PreRolePullR 0.030 -0.097 -0.189 0.054 -0.268 0.049 
PostRolePullR 0.003 -0.112 -0.219 0.014 -0.278 0.023 
PreRolePullL 0.007 -0.088 -0.143 0.075 -0.179 0.086 
PostRolePullL -0.017 -0.098 -0.208 -0.010 -0.240 0.005 
PreRolePullRL 0.018 -0.094 -0.167 0.067 -0.225 0.069 
PostRolePullRL -0.008 -0.106 -0.217 0.001 -0.265 0.014 
PreLongJump 0.009 0.195 0.290 0.114 0.252 0.071 
PostLongJump -0.030 0.222 0.268 0.081 0.256 0.057 
PreRotSBTossR -0.132 0.109 0.154 -0.079 0.166 -0.053 
PostRotSBTossR -0.103 0.056 0.152 -0.034 0.168 -0.002 
PreRotSBTossL -0.126 0.064 0.151 -0.105 0.143 -0.083 
PostRotSBTossL -0.138 0.084 0.163 -0.033 0.172 -0.029 
PreRotSBTossRL -0.130 0.087 0.153 -0.092 0.156 -0.068 
PostRotSBTossRL -0.121 0.071 0.159 -0.034 0.171 -0.016 
PreSledPushPull 0.056 -0.081 -0.228 0.031 -0.320 -0.030 
PostSledPushPull 0.060 -0.203 -0.246 -0.065 -0.340 -0.073 
PreUpperWingatePeakW -0.131 0.082 0.150 -0.046 0.172 -0.113 
PostUpperWingatePeakW -0.214 0.038 0.072 -0.060 0.098 -0.043 
PreUpperWingatePeakWkg -0.092 0.142 0.256 0.023 0.214 -0.092 
PostUpperWingatePeakWkg -0.216 0.060 0.115 -0.018 0.121 0.015 
PreUpperWingateAvgW -0.137 0.093 0.151 -0.083 0.192 -0.145 
PostUpperWingateAvgW -0.188 0.048 0.095 -0.047 0.125 -0.032 
PreUpperWingateAvgWkg -0.094 0.146 0.249 -0.037 0.239 -0.134 
PostUpperWingateAvgWkg -0.174 0.075 0.152 0.002 0.157 0.036 
PreLowerWingatePeakW -0.118 0.162 0.130 -0.024 0.274 -0.054 
PostLowerWingatePeakW -0.126 0.085 0.144 -0.031 0.204 -0.050 
PreLowerWingatePeakWkg -0.034 0.256 0.208 0.059 0.283 -0.030 
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PostLowerWingatePeakWkg -0.065 0.170 0.236 0.062 0.273 0.043 
PreLowerWingateAvgW -0.113 0.144 0.134 -0.048 0.272 -0.045 
PostLowerWingateAvgW -0.089 0.113 0.179 -0.021 0.235 -0.018 
PreLowerWingateAvgWkg -0.069 0.198 0.218 0.051 0.318 0.030 
PostLowerWingateAvgWkg  -0.001 0.203 0.286 0.075 0.312 0.094 
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Table 13. Pearson Correlation Results. Cortisol levels compared to Balance Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. Pre-
testing high stress cortisol and stress-induced cortisol release was positively correlated 
with nearly all aspects of pre-testing Y-Balance performance scores and some post-
testing Y-Balance performance scores.
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    CORTISOL 
    CORT BD1 
CORT 
BD7 
CORT 
BD3 
CORT 
BD9 
CORT 
BD3 - 
BD1 
CORT 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
BALANCE 
PreUpperYBTMedR -0.038 0.144 0.136 -0.102 0.275 0.041 
PostUpperYBTMedR -0.109 0.010 0.038 -0.053 0.146 0.042 
PreUpperYBTILR 0.009 0.200 0.208 -0.011 0.264 0.064 
PostUpperYBTILR -0.124 0.019 0.029 -0.059 0.185 0.082 
PreUpperYBTSLR 0.137 0.059 0.270 0.044 0.296 0.126 
PostUpperYBTSLR 0.081 0.028 0.142 0.162 0.153 0.141 
PreUpperYBTMedL -0.016 0.131 0.150 -0.033 0.224 -0.008 
PostUpperYBTMedL -0.143 0.011 -0.009 -0.105 0.111 0.011 
PreUpperYBTILL -0.056 0.092 0.085 -0.102 0.241 -0.038 
PostUpperYBTILL -0.084 -0.094 0.070 -0.051 0.151 0.090 
PreUpperYBTSLL 0.174 0.059 0.312 0.101 0.255 0.064 
PostUpperYBTSLL 0.087 -0.026 0.145 0.086 0.166 0.100 
PreUpperYBTCOMR 0.117 0.209 0.270 0.070 0.322 0.147 
PostUpperYBTCOMR 0.001 0.060 0.097 0.107 0.185 0.165 
PreUpperYBTCOML 0.107 0.149 0.225 0.066 0.271 0.046 
PostUpperYBTCOML 0.018 -0.011 0.101 0.074 0.166 0.147 
PreUpperYBTRL 0.115 0.178 0.261 0.066 0.310 0.098 
PostUpperYBTRL 0.005 0.029 0.105 0.095 0.183 0.160 
PreLowerYBTAntR 0.056 0.048 0.158 -0.059 0.178 -0.012 
PostLowerYBTAntR -0.094 0.108 0.098 -0.020 0.133 -0.098 
PreLowerYBTAntL 0.085 0.112 0.157 -0.060 0.143 -0.063 
PostLowerYBTAntL -0.020 0.062 0.088 0.036 0.132 0.011 
PreLowerYBTPMR 0.031 0.163 0.269 0.010 0.281 0.010 
PostLowerYBTPMR -0.072 0.097 0.160 -0.016 0.223 -0.019 
PreLowerYBTPML -0.008 0.126 0.222 0.012 0.281 0.014 
PostLowerYBTPML -0.047 0.042 0.132 0.002 0.199 0.038 
PreLowerYBTPLR -0.016 0.088 0.206 -0.045 0.267 0.002 
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PostLowerYBTPLR -0.057 0.123 0.203 0.068 0.267 0.028 
PreLowerYBTPLL 0.011 0.101 0.166 -0.036 0.257 -0.023 
PostLowerYBTPLL -0.039 0.171 0.134 0.060 0.202 0.005 
PreLowerYBTCOMR 0.085 0.159 0.237 0.070 0.294 0.087 
PostLowerYBTCOMR -0.035 0.151 0.148 0.116 0.250 0.057 
PreLowerYBTCOML 0.086 0.153 0.191 0.066 0.280 0.063 
PostLowerYBTCOML 0.013 0.141 0.099 0.143 0.214 0.113 
PreLowerYBTRL 0.086 0.164 0.211 0.065 0.288 0.069 
PostLowerYBTRL  -0.015 0.146 0.128 0.133 0.244 0.087 
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Table 14. Pearson Correlation Results. DHEA-S levels compared to Anthropometric and 
Cardiac Physical Performance measures. Red shaded cells indicate positive correlations 
and blue shaded cells indicate negative correlations. Darker shading represents stronger 
association. Post-testing stress-induced DHEA-S release was positively correlated with 
Abdominal Circumference and pre-resting heart rate, systolic pressure, and post diastolic 
pressure.
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  DHEA-S 
   
DHEAS 
BD1 
DHEAS 
BD7 
DHEAS 
BD3 
DHEAS 
BD9 
DHEAS 
BD3 - 
BD1 
DHEAS 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
ANTHRO-
POMETRICS 
WeightB -0.041 -0.021 -0.114 -0.059 0.026 0.089 
WeightP -0.012 0.017 -0.091 -0.019 0.043 0.103 
BodyFatB 0.136 0.104 -0.016 0.027 -0.037 0.055 
BodyFatP 0.129 0.082 -0.011 0.010 -0.060 0.028 
PreAbCir -0.035 -0.043 -0.145 0.003 -0.014 0.204 
PostAbCir 0.024 0.009 -0.113 0.036 -0.020 0.200 
LMMB   -0.113 -0.096 -0.081 -0.073 0.015 0.026 
LMMP -0.060 -0.011 -0.056 0.001 0.067 0.078 
CARDIAC 
PreRestingHR 0.123 0.068 -0.012 0.257 -0.073 0.321 
PostRestingHR -0.053 0.005 0.020 0.106 0.082 0.099 
PreSystolic 0.006 0.018 -0.032 0.183 0.018 0.262 
PostSystolic -0.054 0.011 0.096 0.143 0.091 0.036 
PreDiastolic 0.156 0.097 0.008 0.167 -0.075 0.186 
PostDiastolic 0.021 0.024 -0.093 0.087 0.006 0.231 
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Table 15. Pearson Correlation Results. DHEA-S levels compared to Agility, Aerobic 
Power, Muscle Endurance, and Core Endurance Physical Performance measures. Red 
shaded cells indicate positive correlations and blue shaded cells indicate negative 
correlations. Darker shading represents stronger association. Pre-testing high stress 
DHEA-S was positively correlated with all aspects of post-testing performance scores 
except VO2 Max and Sit-ups, and negatively correlated with Agility scores. Agility is 
scored as time to course completion, therefore a lower number indicates a better score. 
This pattern was flipped with post-testing stress-induced release DHEA-S levels in that 
they were negatively correlated with most performance scores, and positively correlated 
with Agility. 
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    DHEA-S 
    DHEAS BD1 
DHEAS 
BD7 
DHEAS 
BD3 
DHEAS 
BD9 
DHEAS 
BD3 - 
BD1 
DHEAS 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
AGILITY 
PreAgility -0.101 -0.090 -0.274 -0.127 0.008 0.229 
PostAgility -0.024 -0.055 -0.230 -0.188 -0.047 0.095 
AEROBIC 
POWER 
VO2MaxB -0.028 0.025 0.046 -0.067 0.077 -0.142 
VO2MaxP -0.179 -0.046 -0.053 -0.089 0.183 -0.032 
MUSCLE 
ENDURANCE 
PrePushups -0.081 -0.054 0.264 0.005 0.034 -0.359 
PostPushups -0.036 -0.017 0.216 -0.002 0.026 -0.301 
PreModPullUp -0.030 0.005 0.171 0.081 0.049 -0.141 
PostModPullUp 0.229 0.268 0.436 0.285 0.077 -0.266 
CORE 
ENDURANCE 
PreSitups 0.036 -0.016 0.141 0.081 -0.074 -0.099 
PostSitups 0.011 0.053 0.144 0.077 0.062 -0.109 
PreSupBridgeR -0.058 0.015 0.108 0.036 0.103 -0.107 
PostSupBridgeR 0.114 0.165 0.213 0.113 0.085 -0.162 
PreSupBridgeL -0.033 -0.021 0.178 -0.024 0.016 -0.275 
PostSupBridgeL 0.145 0.149 0.294 0.130 0.017 -0.253 
PreSupBridgeRL -0.049 -0.003 0.150 0.007 0.064 -0.199 
PostSupBridgeRL 0.132 0.160 0.260 0.124 0.052 -0.212 
PreLatBridgeR -0.017 -0.061 0.147 0.011 -0.066 -0.191 
PostLatBridgeR 0.127 0.147 0.318 0.155 0.039 -0.256 
PreLatBridgeL  0.015 0.019 0.189 0.039 0.008 -0.217 
PostLatBridgeL 0.080 0.067 0.225 0.070 -0.014 -0.229 
PreLatBridgeRL -0.002 -0.023 0.174 0.025 -0.031 -0.211 
PostLatBridgeRL 0.106 0.109 0.279 0.115 0.013 -0.250 
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Table 16. Pearson Correlation Results. DHEA-S levels compared to Anaerobic Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. 
DHEA-S levels were associated with very few aspects of Anaerobic Performance.
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    DHEA-S 
    DHEAS BD1 
DHEAS 
BD7 
DHEAS 
BD3 
DHEAS 
BD9 
DHEAS 
BD3 - 
BD1 
DHEAS 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
ANAEROBIC 
POWER 
PreRolePullR -0.040 -0.003 -0.148 -0.060 0.052 0.134 
PostRolePullR -0.062 -0.044 -0.096 -0.047 0.021 0.078 
PreRolePullL -0.073 -0.033 -0.174 -0.124 0.053 0.093 
PostRolePullL -0.020 -0.088 -0.127 -0.034 -0.103 0.136 
PreRolePullRL -0.059 -0.020 -0.165 -0.096 0.054 0.114 
PostRolePullRL -0.041 -0.069 -0.116 -0.041 -0.045 0.111 
PreLongJump 0.043 -0.004 0.224 0.182 -0.066 -0.096 
PostLongJump -0.020 -0.030 0.214 0.105 -0.016 -0.171 
PreRotSBTossR -0.117 -0.095 0.031 0.064 0.023 0.033 
PostRotSBTossR -0.112 -0.108 -0.092 -0.025 -0.003 0.099 
PreRotSBTossL -0.137 -0.150 -0.048 -0.027 -0.029 0.035 
PostRotSBTossL -0.120 -0.128 -0.148 -0.052 -0.022 0.144 
PreRotSBTossRL -0.129 -0.124 -0.009 0.019 -0.003 0.035 
PostRotSBTossRL -0.117 -0.119 -0.121 -0.039 -0.012 0.122 
PreSledPushPull 0.064 0.084 -0.109 -0.048 0.035 0.094 
PostSledPushPull 0.035 -0.055 -0.189 -0.188 -0.131 0.040 
PreUpperWingatePeakW -0.125 -0.050 -0.014 0.120 0.101 0.161 
PostUpperWingatePeakW -0.157 -0.064 -0.077 0.091 0.125 0.214 
PreUpperWingatePeakWkg -0.115 -0.022 0.079 0.138 0.129 0.054 
PostUpperWingatePeakWkg -0.176 -0.062 0.001 0.065 0.155 0.075 
PreUpperWingateAvgW -0.125 -0.095 0.006 0.037 0.033 0.036 
PostUpperWingateAvgW -0.154 -0.076 -0.067 0.058 0.104 0.161 
PreUpperWingateAvgWkg -0.100 -0.069 0.119 0.037 0.038 -0.120 
PostUpperWingateAvgWkg -0.171 -0.073 0.025 0.026 0.131 -0.004 
PreLowerWingatePeakW -0.116 -0.077 0.029 0.047 0.049 0.016 
PostLowerWingatePeakW -0.031 -0.039 0.082 0.160 -0.015 0.075 
PreLowerWingatePeakWkg -0.115 -0.063 0.133 0.007 0.067 -0.175 
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PostLowerWingatePeakWkg -0.026 -0.059 0.231 0.150 -0.051 -0.143 
PreLowerWingateAvgW -0.120 -0.077 0.027 0.008 0.054 -0.028 
PostLowerWingateAvgW -0.029 -0.008 0.064 0.153 0.029 0.092 
PreLowerWingateAvgWkg -0.083 0.007 0.142 0.044 0.127 -0.145 
PostLowerWingateAvgWkg  -0.017 -0.006 0.216 0.143 0.015 -0.129 
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Table 17. Pearson Correlation Results. DHEA-S levels compared to Balance Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. 
DHEA-S levels were associated with very few aspects of Balance.
78 
 
 
    DHEA-S 
    DHEAS BD1 
DHEAS 
BD7 
DHEAS 
BD3 
DHEAS 
BD9 
DHEAS 
BD3 - 
BD1 
DHEAS 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
BALANCE 
PreUpperYBTMedR 0.013 0.069 0.115 0.156 0.083 0.027 
PostUpperYBTMedR -0.062 0.038 0.048 0.132 0.143 0.091 
PreUpperYBTILR 0.168 0.157 0.230 0.185 -0.003 -0.100 
PostUpperYBTILR 0.043 -0.005 0.051 0.054 -0.067 -0.007 
PreUpperYBTSLR 0.118 0.085 0.081 0.012 -0.041 -0.097 
PostUpperYBTSLR 0.097 0.053 0.043 0.042 -0.058 -0.010 
PreUpperYBTMedL -0.045 -0.003 0.002 0.101 0.058 0.116 
PostUpperYBTMedL -0.021 0.076 0.014 0.106 0.142 0.105 
PreUpperYBTILL 0.046 0.052 0.023 0.105 0.013 0.093 
PostUpperYBTILL -0.069 -0.124 -0.112 -0.047 -0.086 0.100 
PreUpperYBTSLL 0.054 0.006 -0.075 -0.092 -0.066 -0.006 
PostUpperYBTSLL 0.027 -0.025 -0.128 -0.081 -0.075 0.082 
PreUpperYBTCOMR 0.165 0.153 0.251 0.155 -0.005 -0.164 
PostUpperYBTCOMR 0.056 0.050 0.115 0.095 -0.005 -0.047 
PreUpperYBTCOML 0.064 0.054 0.053 0.060 -0.009 -0.002 
PostUpperYBTCOML 0.006 -0.012 -0.024 0.003 -0.026 0.037 
PreUpperYBTRL 0.110 0.102 0.152 0.108 -0.003 -0.083 
PostUpperYBTRL 0.040 0.020 0.057 0.055 -0.027 -0.014 
PreLowerYBTAntR 0.067 0.053 0.095 0.077 -0.015 -0.041 
PostLowerYBTAntR -0.019 -0.068 -0.013 0.087 -0.073 0.120 
PreLowerYBTAntL -0.035 -0.063 -0.040 -0.068 -0.044 -0.024 
PostLowerYBTAntL 0.014 -0.032 0.063 0.087 -0.067 0.016 
PreLowerYBTPMR 0.093 0.046 0.087 0.074 -0.062 -0.033 
PostLowerYBTPMR 0.010 -0.052 0.105 -0.003 -0.091 -0.148 
PreLowerYBTPML 0.036 0.008 0.123 0.052 -0.039 -0.109 
PostLowerYBTPML 0.100 0.040 0.051 0.071 -0.080 0.013 
PreLowerYBTPLR 0.123 0.095 0.090 0.026 -0.031 -0.093 
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PostLowerYBTPLR 0.100 0.006 0.087 0.097 -0.131 -0.006 
PreLowerYBTPLL 0.118 0.075 0.049 0.077 -0.054 0.024 
PostLowerYBTPLL 0.094 0.070 0.048 0.049 -0.030 -0.009 
PreLowerYBTCOMR 0.186 0.119 0.195 0.104 -0.085 -0.147 
PostLowerYBTCOMR 0.114 0.010 0.165 0.103 -0.145 -0.106 
PreLowerYBTCOML 0.123 0.057 0.141 0.060 -0.089 -0.124 
PostLowerYBTCOML 0.154 0.081 0.153 0.119 -0.096 -0.071 
PreLowerYBTRL 0.157 0.086 0.176 0.087 -0.093 -0.141 
PostLowerYBTRL  0.135 0.043 0.165 0.116 -0.126 -0.092 
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Table 18. Pearson Correlation Results. NE levels compared to Anthropometric and 
Cardiac Physical Performance measures. Red shaded cells indicate positive correlations 
and blue shaded cells indicate negative correlations. Darker shading represents stronger 
association.
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NOREPINEPHRINE 
  
NE 
BD1 
NE 
BD7 
NE 
BD2 
NE 
BD8 
NE 
BD2 - 
BD1 
NE 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
ANTHRO-
POMETRICS 
WeightB -0.150 0.034 -0.041 -0.012 -0.021 -0.016 
WeightP -0.146 0.048 -0.043 -0.030 -0.023 -0.037 
BodyFatB -0.099 0.049 -0.316 -0.166 -0.306 -0.174 
BodyFatP -0.141 0.027 -0.318 -0.171 -0.302 -0.176 
PreAbCir -0.130 0.073 -0.015 -0.018 0.002 -0.028 
PostAbCir -0.163 0.066 -0.042 -0.035 -0.021 -0.044 
LMMB -0.093 -0.007 0.121 0.069 0.134 0.071 
LMMP -0.075 0.025 0.125 0.058 0.137 0.055 
CARDIAC 
PreRestingHR 0.144 0.050 -0.070 0.054 -0.090 0.048 
PostRestingHR 0.152 -0.044 -0.246 -0.080 -0.269 -0.075 
PreSystolic 0.071 0.150 0.168 0.015 0.160 -0.004 
PostSystolic -0.064 0.044 0.127 0.056 0.137 0.051 
PreDiastolic 0.131 0.110 0.187 0.086 0.171 0.073 
PostDiastolic 0.205 0.206 0.142 0.134 0.116 0.108 
82 
 
 
Table 19. Pearson Correlation Results. NE levels compared to Agility, Aerobic Power, 
Muscle Endurance, and Core Endurance Physical Performance measures. Red shaded 
cells indicate positive correlations and blue shaded cells indicate negative correlations. 
Darker shading represents stronger association.
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    NOREPINEPHRINE 
    NE BD1 
NE 
BD7 
NE 
BD2 
NE 
BD8 
NE 
BD2 - 
BD1 
NE 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
AGILITY 
PreAgility 0.020 0.078 -0.289 -0.129 -0.295 -0.140 
PostAgility 0.023 0.047 -0.323 -0.168 -0.33 -0.176 
AEROBIC POWER 
VO2MaxB -0.019 -0.136 0.279 0.143 0.285 0.162 
VO2MaxP 0.097 -0.118 0.258 0.161 0.248 0.178 
MUSCLE 
ENDURANCE 
PrePushups 0.027 0.043 0.253 0.086 0.252 0.082 
PostPushups 0.044 0.015 0.237 0.063 0.234 0.062 
PreModPullUp -0.003 0.001 0.187 0.151 0.189 0.152 
PostModPullUp -0.021 0.003 0.221 0.121 0.226 0.122 
CORE 
ENDURANCE 
PreSitups 0.092 0.034 0.254 0.095 0.244 0.091 
PostSitups 0.068 0.054 0.174 0.082 0.167 0.076 
PreSupBridgeR -0.002 -0.128 0.058 0.006 0.059 0.022 
PostSupBridgeR 0.095 -0.057 0.028 0.083 0.016 0.091 
PreSupBridgeL 0.076 -0.110 0.127 0.047 0.118 0.061 
PostSupBridgeL 0.096 -0.030 0.061 0.056 0.049 0.061 
PreSupBridgeRL 0.038 -0.123 0.095 0.027 0.091 0.043 
PostSupBridgeRL 0.098 -0.044 0.046 0.071 0.033 0.077 
PreLatBridgeR 0.059 -0.068 0.065 0.129 0.058 0.139 
PostLatBridgeR 0.041 -0.005 0.015 0.108 0.009 0.109 
PreLatBridgeL 0.103 -0.078 0.182 0.174 0.170 0.186 
PostLatBridgeL  0.029 -0.036 0.023 0.117 0.020 0.123 
PreLatBridgeRL 0.085 -0.076 0.130 0.158 0.120 0.169 
PostLatBridgeRL 0.036 -0.022 0.020 0.116 0.015 0.120 
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Table 20. Pearson Correlation Results. NE levels compared to Anaerobic Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association.
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    NOREPINEPHRINE 
    NE BD1 
NE 
BD7 
NE 
BD2 
NE 
BD8 
NE 
BD2 - 
BD1 
NE 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
ANAEROBIC 
POWER 
PreRolePullR 0.116 0.039 -0.211 -0.070 -0.229 -0.076 
PostRolePullR 0.035 -0.050 -0.224 -0.123 -0.231 -0.117 
PreRolePullL 0.068 -0.036 -0.213 -0.093 -0.224 -0.089 
PostRolePullL 0.040 -0.065 -0.195 -0.068 -0.203 -0.061 
PreRolePullRL 0.093 0.000 -0.216 -0.083 -0.231 -0.084 
PostRolePullRL 0.038 -0.059 -0.214 -0.097 -0.222 -0.090 
PreLongJump -0.023 -0.050 0.254 0.175 0.26 0.184 
PostLongJump -0.038 -0.064 0.212 0.152 0.219 0.162 
PreRotSBTossR -0.036 0.101 0.212 0.165 0.219 0.154 
PostRotSBTossR -0.036 0.077 0.218 0.144 0.225 0.135 
PreRotSBTossL -0.026 0.094 0.234 0.163 0.24 0.153 
PostRotSBTossL -0.046 0.058 0.222 0.129 0.231 0.123 
PreRotSBTossRL -0.031 0.098 0.224 0.165 0.231 0.154 
PostRotSBTossRL -0.041 0.068 0.222 0.137 0.23 0.130 
PreSledPushPull 0.043 -0.034 -0.26 -0.151 -0.268 -0.148 
PostSledPushPull 0.045 0.039 -0.241 -0.074 -0.25 -0.079 
PreUpperWingatePeakW -0.056 0.097 0.153 0.065 0.162 0.053 
PostUpperWingatePeakW -0.002 0.136 0.176 0.115 0.178 0.098 
PreUpperWingatePeakWkg -0.042 0.056 0.256 0.099 0.264 0.092 
PostUpperWingatePeakWkg 0.040 0.110 0.275 0.165 0.273 0.152 
PreUpperWingateAvgW -0.059 0.113 0.147 0.082 0.157 0.067 
PostUpperWingateAvgW -0.012 0.148 0.173 0.140 0.177 0.122 
PreUpperWingateAvgWkg -0.046 0.074 0.247 0.118 0.255 0.110 
PostUpperWingateAvgWkg 0.032 0.123 0.274 0.2 0.273 0.185 
PreLowerWingatePeakW -0.141 -0.008 0.146 0.062 0.167 0.064 
PostLowerWingatePeakW -0.061 0.059  0.158 0.059 0.167 0.052 
PreLowerWingatePeakWkg -0.068 -0.067 0.217 0.102 0.229 0.112 
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PostLowerWingatePeakWkg -0.001 0.005 0.277 0.101 0.28 0.101 
PreLowerWingateAvgW -0.128 0.021 0.165 0.056 0.184 0.054 
PostLowerWingateAvgW -0.072 0.062 0.195 0.086 0.206 0.078 
PreLowerWingateAvgWkg -0.086 -0.012 0.275 0.127 0.29 0.130 
PostLowerWingateAvgWkg -0.019 0.008 0.315 0.135 0.321 0.135 
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Table 21. Pearson Correlation Results. NE levels compared to Balance Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. NE 
levels were associated with very few aspects of Balance.
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    NOREPINEPHRINE 
    NE BD1 
NE 
BD7 
NE 
BD2 
NE 
BD8 
NE 
BD2 - 
BD1 
NE 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
BALANCE 
PreUpperYBTMedR -0.017 -0.093 0.150 0.050 0.154 0.062 
PostUpperYBTMedR 0.011 -0.054 0.130 0.022 0.130 0.029 
PreUpperYBTILR -0.122 -0.154 0.063 -0.005 0.080 0.015 
PostUpperYBTILR -0.052 -0.105 0.098 0.041 0.106 0.055 
PreUpperYBTSLR 0.043 -0.043 0.133 0.148 0.128 0.155 
PostUpperYBTSLR 0.060 -0.019 0.107 0.174 0.100 0.178 
PreUpperYBTMedL 0.027 -0.061 0.148 0.039 0.146 0.047 
PostUpperYBTMedL -0.018 -0.047 0.110 -0.015 0.114 -0.009 
PreUpperYBTILL -0.154 -0.104 0.095 0.018 0.116 0.031 
PostUpperYBTILL -0.058 -0.127 0.104 0.021 0.113 0.037 
PreUpperYBTSLL 0.001 -0.023 0.225 0.198 0.227 0.203 
PostUpperYBTSLL 0.019 0.003 0.092 0.123 0.091 0.124 
PreUpperYBTCOMR -0.036 -0.163 0.086 0.035 0.092 0.056 
PostUpperYBTCOMR 0.008 -0.120 0.087 0.052 0.087 0.068 
PreUpperYBTCOML -0.058 -0.125 0.133 0.053 0.142 0.070 
PostUpperYBTCOML -0.021 -0.123 0.079 0.006 0.083 0.022 
PreUpperYBTRL -0.051 -0.147 0.118 0.051 0.126 0.070 
PostUpperYBTRL -0.005 -0.127 0.081 0.034 0.083 0.051 
PreLowerYBTAntR -0.061 -0.071 0.073 0.004 0.082 0.013 
PostLowerYBTAntR -0.136 0.010 0.020 -0.022 0.039 -0.023 
PreLowerYBTAntL -0.145 -0.077 0.121 0.019 0.142 0.029 
PostLowerYBTAntL -0.101 -0.049 0.067 0.066 0.082 0.073 
PreLowerYBTPMR -0.101 -0.120 0.166 0.099 0.182 0.116 
PostLowerYBTPMR -0.108 -0.061 0.133 0.063 0.149 0.071 
PreLowerYBTPML -0.159 -0.102 0.141 0.112 0.164 0.126 
PostLowerYBTPML -0.101 -0.059 0.142 0.044 0.158 0.052 
PreLowerYBTPLR -0.127 -0.045 0.104 0.057 0.123 0.063 
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PostLowerYBTPLR -0.046 -0.014 0.126 0.056 0.133 0.059 
PreLowerYBTPLL -0.147 -0.107 0.121 0.033 0.142 0.048 
PostLowerYBTPLL -0.054 -0.061 0.112 0.071 0.121 0.079 
PreLowerYBTCOMR -0.137 -0.137 0.023 0.053 0.042 0.072 
PostLowerYBTCOMR -0.135 -0.079 -0.015 0.017 0.003 0.028 
PreLowerYBTCOML -0.208 -0.160 0.038 0.054 0.066 0.076 
PostLowerYBTCOML -0.125 -0.107 0.008 0.054 0.025 0.069 
PreLowerYBTRL -0.171 -0.150 0.027 0.051 0.051 0.071 
PostLowerYBTRL  -0.130 -0.092 -0.001 0.041 0.017 0.053 
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Table 22. Pearson Correlation Results. NPY levels compared to Anthropometric and 
Cardiac Physical Performance measures. Red shaded cells indicate positive correlations 
and blue shaded cells indicate negative correlations. Darker shading represents stronger 
association. Pre-testing high stress and stress-induced release of NPY were associated 
with lower Weight. Pre- and post-testing high stress and stress-induced release of NPY 
were strongly associated with lower Abdominal Circumference and Body Fat percentage 
measures. 
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NPY 
  
NPY 
BD1 
NPY 
BD7 
NPY 
BD2 
NPY 
BD8 
NPY 
BD2 - 
BD1 
NPY 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
ANTHRO-
POMETRICS 
WeightB 0.068 0.033 -0.216 -0.162 -0.222 -0.165 
WeightP 0.079 0.053 -0.212 -0.164 -0.219 -0.167 
BodyFatB -0.003 -0.007 -0.396 -0.347 -0.4 -0.35 
BodyFatP -0.019 -0.006 -0.399 -0.355 -0.402 -0.358 
PreAbCir 0.098 0.031 -0.264 -0.238 -0.272 -0.242 
PostAbCir 0.115 0.085 -0.26 -0.232 -0.268 -0.238 
LMMB 0.069 0.038 0.004 0.027 0.000 0.026 
LMMP 0.086 0.057 -0.002 0.027 -0.006 0.025 
CARDIAC 
PreRestingHR -0.166 -0.126 -0.131 -0.088 -0.123 -0.084 
PostRestingHR -0.043 -0.056 -0.009 0.057 -0.008 0.060 
PreSystolic 0.110 0.153 -0.048 -0.001 -0.054 -0.007 
PostSystolic 0.159 0.136 -0.026 -0.072 -0.034 -0.078 
PreDiastolic 0.105 0.080 0.021 -0.024 0.017 -0.028 
PostDiastolic 0.042 -0.033 -0.043 -0.069 -0.045 -0.069 
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Table 23. Pearson Correlation Results. NPY levels compared to Agility, Aerobic Power, 
Muscle Endurance, and Core Endurance Physical Performance measures. Red shaded 
cells indicate positive correlations and blue shaded cells indicate negative correlations. 
Darker shading represents stronger association. Pre- and post-testing high stress and 
stress-induced release of NPY were strongly associated with better scores for every 
aspect of Agility, Aerobic Power, Muscle Endurance, and Core Endurance.
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    NPY 
    NPY BD1 
NPY 
BD7 
NPY 
BD2 
NPY 
BD8 
NPY 
BD2 - 
BD1 
NPY 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
AGILITY 
PreAgility -0.049 -0.159 -0.302 -0.255 -0.302 -0.25 
PostAgility -0.093 -0.154 -0.291 -0.226 -0.289 -0.222 
AEROBIC POWER 
VO2MaxB -0.149 -0.060 0.323 0.188 0.334 0.192 
VO2MaxP -0.151 -0.137 0.312 0.262 0.323 0.27 
MUSCLE 
ENDURANCE 
PrePushups 0.003 0.086 0.271 0.225 0.274 0.223 
PostPushups 0.021 0.115 0.296 0.255 0.298 0.252 
PreModPullUp 0.041 0.125 0.328 0.256 0.329 0.253 
PostModPullUp 0.077 0.098 0.317 0.263 0.316 0.261 
CORE 
ENDURANCE 
PreSitups -0.034 0.057 0.321 0.19 0.326 0.189 
PostSitups 0.022 0.054 0.321 0.223 0.323 0.223 
PreSupBridgeR 0.029 0.103 0.31 0.279 0.311 0.277 
PostSupBridgeR 0.088 0.023 0.323 0.267 0.322 0.269 
PreSupBridgeL 0.051 0.131 0.329 0.3 0.33 0.297 
PostSupBridgeL 0.21 0.163 0.354 0.298 0.346 0.293 
PreSupBridgeRL 0.041 0.121 0.33 0.299 0.331 0.296 
PostSupBridgeRL 0.155 0.097 0.347 0.29 0.342 0.288 
PreLatBridgeR 0.065 0.086 0.423 0.377 0.424 0.377 
PostLatBridgeR 0.069 0.020 0.368 0.304 0.368 0.306 
PreLatBridgeL 0.024 0.037 0.423 0.339 0.425 0.341 
PostLatBridgeL -0.008 -0.035 0.369 0.285 0.373 0.289 
PreLatBridgeRL   0.046 0.064 0.44 0.372 0.442 0.373 
PostLatBridgeRL 0.031 -0.008 0.381 0.304 0.383 0.308 
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Table 24. Pearson Correlation Results. NPY levels compared to Anaerobic Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. NPY 
levels were associated with very few aspects of Anaerobic Physical Performance.
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    NPY 
    NPY BD1 
NPY 
BD7 
NPY 
BD2 
NPY 
BD8 
NPY 
BD2 - 
BD1 
NPY 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
ANAEROBIC 
POWER 
PreRolePullR 0.025 -0.114 -0.069 -0.043 -0.070 -0.038 
PostRolePullR 0.056 -0.065 -0.101 -0.049 -0.105 -0.047 
PreRolePullL 0.035 -0.099 -0.030 -0.038 -0.032 -0.034 
PostRolePullL 0.014 -0.093 -0.071 -0.036 -0.072 -0.032 
PreRolePullRL 0.031 -0.108 -0.050 -0.041 -0.052 -0.037 
PostRolePullRL 0.036 -0.082 -0.088 -0.043 -0.090 -0.040 
PreLongJump 0.042 0.103 0.216 0.158 0.216 0.155 
PostLongJump 0.044 0.048 0.251 0.197 0.251 0.197 
PreRotSBTossR 0.020 0.030 0.061 0.013 0.060 0.012 
PostRotSBTossR 0.030 0.018 0.054 0.020 0.053 0.020 
PreRotSBTossL -0.001 0.013 0.034 0.018 0.034 0.017 
PostRotSBTossL 0.020 0.016 0.049 0.029 0.049 0.029 
PreRotSBTossRL 0.010 0.022 0.048 0.015 0.048 0.014 
PostRotSBTossRL 0.025 0.017 0.052 0.025 0.052 0.024 
PreSledPushPull -0.040 -0.074 -0.128 -0.074 -0.127 -0.071 
PostSledPushPull -0.142 -0.115 -0.161 -0.100 -0.155 -0.096 
PreUpperWingatePeakW 0.052 0.059 0.002 0.001 -0.001 -0.002 
PostUpperWingatePeakW 0.077 0.097 -0.038 -0.027 -0.043 -0.032 
PreUpperWingatePeakWkg 0.003 0.040 0.107 0.078 0.108 0.076 
PostUpperWingatePeakWkg 0.027 0.083 0.072 0.048 0.072 0.045 
PreUpperWingateAvgW 0.049 0.067 0.032 0.019 0.030 0.016 
PostUpperWingateAvgW 0.077 0.080 -0.008 0.001 -0.012 -0.003 
PreUpperWingateAvgWkg -0.004 0.051 0.147 0.104 0.149 0.103 
PostUpperWingateAvgWkg 0.026 0.061 0.122 0.097 0.122 0.095 
PreLowerWingatePeakW 0.027 0.043 0.062 -0.001 0.061 -0.003 
PostLowerWingatePeakW 0.159 0.129 0.037 0.040 0.029 0.034 
PreLowerWingatePeakWkg -0.050 0.006 0.232 0.154 0.237 0.155 
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PostLowerWingatePeakWkg 0.139 0.155 0.251 0.21 0.246 0.205 
PreLowerWingateAvgW 0.021 0.047 0.085 0.029 0.085 0.027 
PostLowerWingateAvgW 0.153 0.138 0.085 0.086 0.078 0.081 
PreLowerWingateAvgWkg -0.013 0.009 0.262 0.179 0.266 0.180 
PostLowerWingateAvgWkg 0.131 0.164 0.315 0.275 0.312 0.27 
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Table 25. Pearson Correlation Results. NPY levels compared to Balance Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association.
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    NPY 
    NPY BD1 
NPY 
BD7 
NPY 
BD2 
NPY 
BD8 
NPY 
BD2 - 
BD1 
NPY 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
BALANCE 
PreUpperYBTMedR 0.102 0.063 0.140 0.083 0.136 0.081 
PostUpperYBTMedR 0.035 0.033 0.114 0.053 0.113 0.053 
PreUpperYBTILR 0.159 0.118 0.173 0.135 0.167 0.131 
PostUpperYBTILR 0.130 0.064 0.157 0.057 0.151 0.055 
PreUpperYBTSLR 0.067 -0.001 0.214 0.279 0.212 0.282 
PostUpperYBTSLR 0.057 0.024 0.233 0.273 0.232 0.275 
PreUpperYBTMedL 0.079 -0.013 0.136 0.061 0.133 0.062 
PostUpperYBTMedL 0.059 0.048 0.042 0.018 0.039 0.016 
PreUpperYBTILL 0.066 0.045 0.113 0.048 0.110 0.047 
PostUpperYBTILL 0.075 0.042 0.092 0.003 0.089 0.001 
PreUpperYBTSLL 0.001 -0.035 0.192 0.259 0.193 0.262 
PostUpperYBTSLL 0.014 -0.009 0.193 0.256 0.194 0.259 
PreUpperYBTCOMR 0.086 0.068 0.256 0.2 0.254 0.199 
PostUpperYBTCOMR 0.046 0.046 0.256 0.156 0.256 0.155 
PreUpperYBTCOML 0.011 -0.004 0.214 0.148 0.216 0.149 
PostUpperYBTCOML 0.016 0.031 0.191 0.121 0.192 0.121 
PreUpperYBTRL 0.050 0.031 0.24 0.179 0.24 0.179 
PostUpperYBTRL 0.032 0.040 0.231 0.145 0.232 0.144 
PreLowerYBTAntR -0.034 -0.007 -0.022 0.034 -0.021 0.035 
PostLowerYBTAntR 0.004 0.012 0.071 0.032 0.072 0.031 
PreLowerYBTAntL -0.102 -0.066 0.036 0.037 0.042 0.040 
PostLowerYBTAntL -0.039 -0.052 0.121 0.118 0.124 0.121 
PreLowerYBTPMR 0.031 0.003 0.130 0.125 0.130 0.126 
PostLowerYBTPMR -0.024 -0.020 0.097 0.082 0.099 0.084 
PreLowerYBTPML 0.003 0.033 0.147 0.126 0.149 0.126 
PostLowerYBTPML -0.039 -0.046 0.064 0.088 0.067 0.091 
PreLowerYBTPLR 0.010 0.050 0.091 0.136 0.092 0.135 
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PostLowerYBTPLR 0.027 0.059 0.106 0.127 0.106 0.125 
PreLowerYBTPLL 0.023 0.011 0.078 0.111 0.078 0.112 
PostLowerYBTPLL 0.009 -0.001 0.079 0.097 0.079 0.098 
PreLowerYBTCOMR -0.020 0.020 0.184 0.193 0.187 0.194 
PostLowerYBTCOMR -0.021 0.022 0.209 0.172 0.213 0.173 
PreLowerYBTCOML -0.053 -0.001 0.202 0.186 0.207 0.188 
PostLowerYBTCOML -0.065 -0.030 0.204 0.193 0.21 0.196 
PreLowerYBTRL -0.034 0.007 0.199 0.194 0.203 0.196 
PostLowerYBTRL -0.046 -0.007 0.211 0.188 0.215 0.19 
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Table 26. Pearson Correlation Results. Serotonin levels compared to Anthropometric and 
Cardiac Physical Performance measures. Red shaded cells indicate positive correlations 
and blue shaded cells indicate negative correlations. Darker shading represents stronger 
association. Resting serotonin was associated with lower systolic pressure.
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    SEROTONIN 
    SERO BD1 
SERO 
BD7 
SERO 
BD2 
SERO 
BD8 
SERO 
BD2 - 
BD1 
SERO 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
ANTHRO-
POMETRICS 
WeightB 0.030 0.093 -0.013 -0.004 -0.051 -0.116 
WeightP 0.033 0.095 -0.004 0.002 -0.042 -0.111 
BodyFatB -0.098 -0.088 -0.076 -0.096 -0.002 -0.032 
BodyFatP -0.089 -0.094 -0.068 -0.088 0.000 -0.012 
PreAbCir 0.010 0.073 0.001 -0.028 -0.009 -0.126 
PostAbCir 0.031 0.093 -0.005 0.001 -0.041 -0.109 
LMMB 0.076 0.123 0.029 0.044 -0.041 -0.084 
LMMP 0.073 0.127 0.026 0.044 -0.043 -0.090 
CARDIAC 
PreRestingHR 0.058 0.041 0.056 0.084 0.018 0.070 
PostRestingHR 0.082 0.018 0.121 0.104 0.084 0.126 
PreSystolic 0.248 0.291 0.116 0.203 -0.103 -0.058 
PostSystolic 0.213 0.181 0.078 0.050 -0.120 -0.144 
PreDiastolic 0.129 0.123 0.056 0.070 -0.059 -0.047 
PostDiastolic  0.040 0.077 0.004 -0.061 -0.037 -0.177 
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Table 27. Pearson Correlation Results. Serotonin levels compared to Agility, Aerobic 
Power, Muscle Endurance, and Core Endurance Physical Performance measures. Red 
shaded cells indicate positive correlations and blue shaded cells indicate negative 
correlations. Darker shading represents stronger association. Resting serotonin was 
weakly associated with better post-testing Agility and Sit-up scores.
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    SEROTONIN 
    SERO BD1 
SERO 
BD7 
SERO 
BD2 
SERO 
BD8 
SERO 
BD2 - 
BD1 
SERO 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
AGILITY 
PreAgility -0.176 -0.159 -0.145 -0.151 -0.016 -0.024 
PostAgility -0.228 -0.194 -0.177 -0.188 -0.004 -0.035 
AEROBIC POWER 
VO2MaxB 0.114 0.023 0.120 0.069 0.048 0.070 
VO2MaxP 0.165 0.077 0.123 0.074 -0.003 0.013 
MUSCLE 
ENDURANCE 
PrePushups 0.154 0.173 0.140 0.103 0.033 -0.060 
PostPushups 0.166 0.202 0.132 0.132 0.009 -0.053 
PreModPullUp 0.128 0.133 0.123 0.004 0.037 -0.153 
PostModPullUp 0.128 0.177 0.142 0.093 0.064 -0.079 
CORE 
ENDURANCE 
PreSitups 0.183 0.152 0.108 0.058 -0.044 -0.098 
PostSitups 0.201 0.194 0.138 0.079 -0.022 -0.119 
PreSupBridgeR 0.058 0.021 0.106 -0.001 0.089 -0.026 
PostSupBridgeR 0.070 0.059 0.084 0.000 0.044 -0.070 
PreSupBridgeL 0.081 0.032 0.139 0.046 0.110 0.027 
PostSupBridgeL -0.002 0.009 0.028 -0.048 0.042 -0.078 
PreSupBridgeRL 0.072 0.027 0.126 0.023 0.103 0.000 
PostSupBridgeRL 0.033 0.034 0.056 -0.025 0.044 -0.076 
PreLatBridgeR 0.115 0.081 0.2 0.108 0.161 0.057 
PostLatBridgeR 0.044 0.047 0.082 0.049 0.069 0.013 
PreLatBridgeL 0.100 0.042 0.141 0.075 0.093 0.056 
PostLatBridgeL 0.015 0.002 0.073 0.012 0.088 0.015 
PreLatBridgeRL 0.112 0.064 0.177 0.095 0.132 0.059 
PostLatBridgeRL   0.030 0.025 0.080 0.031 0.081 0.015 
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Table 28. Pearson Correlation Results. Serotonin levels compared to Anaerobic Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. Pre- 
and post-testing resting serotonin levels were associated with better scores for nearly 
every aspect of Anaerobic Physical Performance.
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    SEROTONIN 
    SERO BD1 
SERO 
BD7 
SERO 
BD2 
SERO 
BD8 
SERO 
BD2 - 
BD1 
SERO 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
ANAEROBIC 
POWER 
PreRolePullR -0.22 -0.196 -0.143 -0.161 0.035 0.005 
PostRolePullR -0.206 -0.235 -0.169 -0.164 -0.017 0.046 
PreRolePullL -0.236 -0.227 -0.165 -0.167 0.020 0.034 
PostRolePullL -0.163 -0.192 -0.170 -0.135 -0.067 0.038 
PreRolePullRL -0.233 -0.216 -0.157 -0.167 0.027 0.020 
PostRolePullRL -0.188 -0.218 -0.174 -0.153 -0.044 0.043 
PreLongJump 0.258 0.235 0.193 0.157 -0.004 -0.057 
PostLongJump 0.22 0.201 0.203 0.129 0.052 -0.057 
PreRotSBTossR 0.276 0.245 0.194 0.152 -0.023 -0.077 
PostRotSBTossR 0.236 0.228 0.160 0.110 -0.027 -0.116 
PreRotSBTossL 0.264 0.234 0.166 0.123 -0.049 -0.103 
PostRotSBTossL 0.211 0.216 0.145 0.102 -0.022 -0.113 
PreRotSBTossRL 0.272 0.242 0.182 0.139 -0.036 -0.090 
PostRotSBTossRL 0.225 0.224 0.154 0.107 -0.024 -0.115 
PreSledPushPull -0.235 -0.228 -0.197 -0.166 -0.026 0.037 
PostSledPushPull -0.208 -0.216 -0.179 -0.173 -0.029 0.012 
PreUpperWingatePeakW 0.169 0.23 0.128 0.093 0.001 -0.146 
PostUpperWingatePeakW 0.128 0.164 0.074 0.071 -0.034 -0.096 
PreUpperWingatePeakWkg 0.183 0.221 0.148 0.083 0.016 -0.149 
PostUpperWingatePeakWkg 0.137 0.155 0.088 0.071 -0.023 -0.086 
PreUpperWingateAvgW 0.154 0.234 0.129 0.093 0.019 -0.151 
PostUpperWingateAvgW 0.122 0.169 0.095 0.078 0.004 -0.092 
PreUpperWingateAvgWkg 0.162 0.221 0.148 0.085 0.039 -0.146 
PostUpperWingateAvgWkg 0.131 0.161 0.116 0.083 0.023 -0.077 
PreLowerWingatePeakW 0.150 0.138 0.069 0.039 -0.049 -0.093 
PostLowerWingatePeakW 0.234 0.213 0.162 0.144 -0.022 -0.052 
PreLowerWingatePeakWkg 0.137 0.086 0.056 0.036 -0.054 -0.042 
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PostLowerWingatePeakWkg 0.254 0.182 0.176 0.128 -0.022 -0.037 
PreLowerWingateAvgW 0.153 0.120 0.070 0.039 -0.050 -0.074 
PostLowerWingateAvgW 0.218 0.203 0.168 0.144 0.004 -0.040 
PreLowerWingateAvgWkg 0.166 0.093 0.067 0.075 -0.068 0.005 
PostLowerWingateAvgWkg  0.217 0.156 0.173 0.119 0.013 -0.019 
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Table 29. Pearson Correlation Results. Serotonin levels compared to Balance Physical 
Performance measures. Red shaded cells indicate positive correlations and blue shaded 
cells indicate negative correlations. Darker shading represents stronger association. 
Serotonin was associated with very few aspects of Balance.
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    SEROTONIN 
    SERO BD1 
SERO 
BD7 
SERO 
BD2 
SERO 
BD8 
SERO 
BD2 - 
BD1 
SERO 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
BALANCE 
PreUpperYBTMedR 0.144 0.072 0.079 0.025 -0.044 -0.050 
PostUpperYBTMedR 0.188 0.115 0.085 0.083 -0.083 -0.019 
PreUpperYBTILR 0.043 -0.012 0.045 0.043 0.018 0.075 
PostUpperYBTILR 0.116 0.116 0.125 0.076 0.054 -0.030 
PreUpperYBTSLR 0.217 0.146 0.208 0.128 0.062 0.008 
PostUpperYBTSLR 0.244 0.151 0.227 0.166 0.059 0.055 
PreUpperYBTMedL 0.148 0.110 0.038 0.045 -0.107 -0.067 
PostUpperYBTMedL 0.140 0.098 0.074 0.072 -0.047 -0.015 
PreUpperYBTILL 0.104 0.054 0.082 0.064 0.003 0.027 
PostUpperYBTILL 0.130 0.133 0.090 0.083 -0.012 -0.042 
PreUpperYBTSLL 0.22 0.112 0.161 0.080 -0.008 -0.019 
PostUpperYBTSLL 0.216 0.135 0.202 0.136 0.055 0.033 
PreUpperYBTCOMR 0.125 0.020 0.081 0.041 -0.020 0.034 
PostUpperYBTCOMR 0.198 0.108 0.137 0.104 -0.019 0.018 
PreUpperYBTCOML 0.154 0.052 0.063 0.039 -0.077 -0.007 
PostUpperYBTCOML 0.185 0.111 0.110 0.096 -0.043 0.004 
PreUpperYBTRL 0.147 0.037 0.079 0.044 -0.047 0.019 
PostUpperYBTRL 0.197 0.109 0.125 0.097 -0.035 0.007 
PreLowerYBTAntR -0.025 -0.089 -0.016 -0.085 0.005 -0.014 
PostLowerYBTAntR 0.034 -0.081 -0.028 -0.075 -0.078 -0.009 
PreLowerYBTAntL -0.001 0.005 -0.023 -0.095 -0.032 -0.140 
PostLowerYBTAntL 0.053 -0.014 0.065 0.006 0.036 0.024 
PreLowerYBTPMR 0.160 0.174 0.135 0.115 0.020 -0.045 
PostLowerYBTPMR 0.078 0.091 0.082 0.046 0.033 -0.043 
PreLowerYBTPML 0.096 0.141 0.121 0.085 0.070 -0.047 
PostLowerYBTPML 0.127 0.118 0.089 0.094 -0.012 -0.007 
PreLowerYBTPLR 0.073 0.143 0.080 0.134 0.035 0.020 
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PostLowerYBTPLR 0.138 0.139 0.131 0.116 0.039 -0.002 
PreLowerYBTPLL 0.131 0.195 0.144 0.164 0.064 0.000 
PostLowerYBTPLL 0.107 0.102 0.066 0.099 -0.021 0.019 
PreLowerYBTCOMR 0.013 0.035 0.084 0.079 0.106 0.070 
PostLowerYBTCOMR 0.005 -0.020 0.066 0.036 0.089 0.075 
PreLowerYBTCOML 0.010 0.070 0.103 0.073 0.137 0.020 
PostLowerYBTCOML 0.026 0.002 0.084 0.083 0.092 0.115 
PreLowerYBTRL 0.008 0.051 0.096 0.076 0.129 0.047 
PostLowerYBTRL   0.021 -0.005 0.080 0.064 0.091 0.096 
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Table 30. Pearson Correlation Results. Cortisol levels compared to Executive Function 
and Fluid Intelligence Cognitive Performance measures. Red shaded cells indicate 
positive correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. Cortisol tended to be negatively correlated with reaction 
time (faster responses) and had mixed effects on test accuracy for aspects of both the 
Executive Function and Fluid Intelligence tasks.
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    CORTISOL 
    CORT BD1 
CORT 
BD7 
CORT 
BD3 
CORT 
BD9 
CORT 
BD3 - 
BD1 
CORT 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
EXECUTIVE 
FUNCTION 
SDMTB 0.058 0.178 0.012 0.146 0.039 -0.088 
SDMTP 0.172 0.223 0.157 0.200 -0.016 -0.067 
PreKeepTrackWordsRecalled 0.182 0.295 0.278 0.182 0.182 0.058 
PreKeepTrackMeanRT -0.072 -0.116 -0.050 -0.053 0.037 0.126 
PreKeepTrackMeanAccRT -0.030 -0.112 0.114 -0.192 0.160 0.060 
PostKeepTrackWordsRecalled 0.092 0.090 0.209 0.074 0.172 0.120 
PostKeepTrackMeanRT -0.065 -0.088 -0.109 -0.029 -0.016 0.061 
PostKeepTrackMeanAccRT -0.005 0.044 0.095 0.121 -0.001 -0.053 
PreStroopCongruousRT -0.251 -0.170 -0.179 -0.127 -0.137 -0.142 
PreStroopCongruousAcc -0.116 -0.207 -0.291 -0.187 -0.055 -0.033 
PreStroopIncongruousRT -0.259 -0.154 -0.236 -0.099 -0.080 -0.084 
PreStroopIncongruousAcc -0.122 0.085 0.013 0.028 0.102 -0.052 
PreStroopEffect -0.175 -0.070 -0.229 -0.019 0.036 0.036 
PreStroopCost -0.104 0.027 -0.185 0.047 -0.019 -0.003 
PreStroopBenefit -0.199 -0.272 -0.128 -0.182 0.163 0.116 
PostStroopCongruousRT -0.183 -0.249 -0.122 -0.023 -0.095 -0.095 
PostStroopCongruousAcc 0.010 -0.086 0.053 0.038 0.100 0.031 
PostStroopIncongruousRT -0.093 -0.254 -0.032 0.089 -0.021 -0.036 
PostStroopIncongruousAcc 0.016 -0.047 0.138 0.052 0.122 0.027 
PostStroopEffect 0.023 -0.186 0.068 0.179 0.081 0.052 
PostStroopCost 0.033 -0.176 0.114 0.175 0.073 0.068 
PostStroopBenefit -0.044 0.054 -0.187 -0.073 0.006 -0.062 
FLUID 
INTELLIGENCE 
PreNumberSeriesCorrectTrials -0.016 0.025 0.100 0.021 0.038 0.078 
PreNumberSeriesCorrectTrialRT 0.125 0.128 -0.158 0.014 -0.162 -0.210 
PostNumberSeriesCorrectTrials 0.130 0.036 0.240 0.142 0.096 0.125 
PostNumberSeriesCorrectTrialRT -0.322 -0.222 -0.277 -0.217 -0.015 0.061 
PreLetterSetsCorrectTrials 0.159 0.225 0.134 0.168 -0.033 0.077 
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PreLetterSetsCorrectTrialRT -0.143 0.047 -0.071 -0.042 -0.015 -0.122 
PostLetterSetsCorrectTrials 0.097 0.310 0.350 0.263 0.164 0.094 
PostLetterSetsCorrectTrialRT 0.032 -0.020 0.055 -0.031 0.056 0.090 
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Table 31. Pearson Correlation Results. Cortisol levels compared to Working Memory 
and Episodic Memory Cognitive Performance measures. Red shaded cells indicate 
positive correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. Cortisol tended to be negatively associated with the Free 
Recall Episodic Memory tasks, but had mixed effects on Working Memory tasks.
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    CORTISOL 
    CORT BD1 
CORT 
BD7 
CORT 
BD3 
CORT 
BD9 
CORT 
BD3 - 
BD1 
CORT 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
WORKING 
MEMORY 
PreRotationSpanTotal -0.094 0.082 0.107 0.049 0.131 -0.007 
PreRotationSpanAbsoluteScore -0.047 -0.026 0.032 -0.018 0.105 -0.010 
PreRotationSpanRotationErrors 0.179 -0.162 -0.208 -0.103 -0.213 -0.075 
PreRotationSpanSpeedErrors 0.042 -0.206 -0.290 -0.222 -0.198 -0.052 
PreRotationSpanAccuracyErrors 0.279 0.023 0.078 0.166 -0.112 -0.072 
PostRotationSpanTotal -0.032 -0.065 0.165 0.048 0.078 -0.016 
PostRotationSpanAbsoluteScore 0.089 -0.132 0.035 0.002 -0.144 -0.083 
PostRotationSpanRotationErrors 0.035 -0.155 -0.238 -0.055 -0.168 -0.144 
PostRotationSpanSpeedErrors -0.064 -0.073 -0.332 -0.128 -0.181 -0.191 
PostRotationSpanAccuracyErrors 0.168 -0.177 0.071 0.065 -0.019 0.078 
PreSymmetrySpanTotal 0.063 0.223 0.170 0.128 0.156 0.039 
PreSymmetrySpanAbsoluteScore -0.068 0.121 0.045 0.000 0.145 -0.002 
PreSymmetrySpanSymmetryErrors -0.112 -0.020 -0.088 -0.181 -0.127 -0.269 
PreSymmetrySpanSpeedErrors -0.045 0.009 0.006 0.052 -0.030 -0.087 
PreSymmetrySpanAccuracyErrors -0.107 -0.027 -0.104 -0.230 -0.126 -0.259 
PostSymmetrySpanTotal 0.081 0.153 0.236 0.329 0.130 0.090 
PostSymmetrySpanAbsoluteScore 0.143 0.042 0.224 0.212 0.157 0.116 
PostSymmetrySpanSymmetryErrors -0.190 -0.024 -0.136 -0.233 -0.082 -0.205 
PostSymmetrySpanSpeedErrors 0.099 0.130 0.154 -0.017 0.071 -0.078 
PostSymmetrySpanAccuracyErrors -0.261 -0.082 -0.224 -0.256 -0.129 -0.193 
EPISODIC 
MEMORY 
PreIFR_WordsWordsRecalled 0.166 0.018 0.013 0.014 -0.119 0.011 
PostIFR_WordsWordsRecalled 0.205 0.099 0.344 0.222 0.022 0.054 
PreIFR_PicturesWordsRecalled 0.263 0.163 0.221 0.221 0.072 0.114 
PostIFR_PicturesWordsRecalled 0.103 0.108 0.124 0.045 0.036 -0.019 
PrePairedAssociatesWordsRecalled 0.136 0.105 0.005 0.092 -0.115 0.000 
PostPairedAssociatesWordsRecalled 0.102 -0.002 -0.038 0.112 -0.077 0.161 
PrePairedAssociatesDelayWordsRecalled 0.163 0.096 -0.027 0.055 -0.085 0.000 
115 
 
 
PostPairedAssociatesDelayWordsRecalled 0.107 0.052 -0.042 0.148 -0.101 0.151 
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Table 32. Pearson Correlation Results. DHEA-S levels compared to Executive Function 
and Fluid Intelligence Cognitive Performance measures. Red shaded cells indicate 
positive correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. Resting DHEA-S tended to be positively correlated with 
the Keep Track Executive Function tasks and some aspects of Fluid Intelligence tasks.
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    DHEA-S 
    DHEAS BD1 
DHEAS 
BD7 
DHEAS 
BD3 
DHEAS 
BD9 
DHEAS 
BD3 - 
BD1 
DHEAS 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
EXECUTIVE 
FUNCTION 
SDMTB -0.049 -0.067 -0.065 0.100 -0.031 0.208 
SDMTP -0.075 -0.022 -0.126 -0.001 0.072 0.173 
PreKeepTrackWordsRecalled 0.248 0.259 0.112 0.149 0.035 0.020 
PreKeepTrackMeanRT -0.138 -0.145 -0.014 -0.090 -0.021 -0.087 
PreKeepTrackMeanAccRT 0.206 0.185 0.167 -0.015 -0.015 -0.249 
PostKeepTrackWordsRecalled 0.261 0.297 0.059 0.121 0.074 0.061 
PostKeepTrackMeanRT -0.039 -0.005 0.159 0.028 0.048 -0.187 
PostKeepTrackMeanAccRT -0.177 -0.205 -0.149 -0.216 -0.056 -0.049 
PreStroopCongruousRT -0.036 0.055 -0.062 0.033 0.132 0.124 
PreStroopCongruousAcc -0.008 0.110 -0.091 0.017 0.175 0.147 
PreStroopIncongruousRT 0.073 0.062 0.058 0.088 -0.011 0.024 
PreStroopIncongruousAcc 0.003 -0.012 -0.085 0.026 -0.023 0.149 
PreStroopEffect 0.196 0.045 0.202 0.128 -0.207 -0.127 
PreStroopCost 0.175 0.063 0.187 0.104 -0.152 -0.136 
PreStroopBenefit 0.069 -0.043 0.054 0.073 -0.160 0.012 
PostStroopCongruousRT 0.004 0.058 0.038 0.028 0.081 -0.019 
PostStroopCongruousAcc 0.058 0.074 0.086 0.066 0.028 -0.041 
PostStroopIncongruousRT 0.050 0.033 0.082 0.006 -0.022 -0.107 
PostStroopIncongruousAcc 0.040 0.104 0.113 0.121 0.097 -0.014 
PostStroopEffect 0.081 -0.001 0.103 -0.018 -0.115 -0.164 
PostStroopCost 0.108 0.052 0.133 0.029 -0.075 -0.150 
PostStroopBenefit -0.129 -0.171 -0.152 -0.144 -0.073 0.039 
FLUID 
INTELLIGENCE 
PreNumberSeriesCorrectTrials 0.162 0.179 0.157 0.322 0.038 0.164 
PreNumberSeriesCorrectTrialRT 0.113 0.175 0.096 0.151 0.101 0.046 
PostNumberSeriesCorrectTrials 0.202 0.221 0.115 0.113 0.044 -0.025 
PostNumberSeriesCorrectTrialRT -0.015 -0.101 -0.199 -0.130 -0.128 0.122 
PreLetterSetsCorrectTrials 0.189 0.226 0.067 0.105 0.070 0.032 
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PreLetterSetsCorrectTrialRT -0.098 -0.008 -0.004 0.063 0.126 0.080 
PostLetterSetsCorrectTrials 0.031 0.200 0.157 0.174 0.253 -0.012 
PostLetterSetsCorrectTrialRT 0.245 0.106 0.287 0.143 -0.186 -0.229 
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Table 33. Pearson Correlation Results. DHEA-S levels compared to Working Memory 
and Episodic Memory Cognitive Performance measures. Red shaded cells indicate 
positive correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. DHEA-S tended to be positively associated with better 
scores on the Free Recall Episodic Memory tasks, but had mixed effects on Working 
Memory tasks.
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    DHEA-S 
    DHEAS BD1 
DHEAS 
BD7 
DHEAS 
BD3 
DHEAS 
BD9 
DHEAS 
BD3 - 
BD1 
DHEAS 
BD9 - 
BD7 
    Low Stress High Stress Stress Change 
WORKING 
MEMORY 
PreRotationSpanTotal -0.061 -0.147 -0.002 0.035 -0.132 0.043 
PreRotationSpanAbsoluteScore 0.052 0.015 -0.004 -0.050 -0.051 -0.055 
PreRotationSpanRotationErrors -0.178 0.048 -0.078 -0.001 0.320 0.107 
PreRotationSpanSpeedErrors -0.063 0.046 -0.051 0.070 0.157 0.154 
PreRotationSpanAccuracyErrors -0.209 0.021 -0.064 -0.085 0.325 -0.012 
PostRotationSpanTotal 0.155 0.138 0.203 0.208 -0.013 -0.035 
PostRotationSpanAbsoluteScore 0.029 0.101 0.286 0.137 0.109 -0.235 
PostRotationSpanRotationErrors -0.054 0.086 0.015 -0.041 0.203 -0.070 
PostRotationSpanSpeedErrors 0.003 0.073 0.058 -0.004 0.104 -0.085 
PostRotationSpanAccuracyErrors -0.096 0.054 -0.049 -0.066 0.215 -0.011 
PreSymmetrySpanTotal 0.050 0.158 0.071 0.170 0.163 0.103 
PreSymmetrySpanAbsoluteScore 0.021 0.070 0.057 0.174 0.075 0.127 
PreSymmetrySpanSymmetryErrors 0.022 0.057 0.059 0.004 0.054 -0.076 
PreSymmetrySpanSpeedErrors 0.018 0.015 0.035 0.015 -0.003 -0.031 
PreSymmetrySpanAccuracyErrors 0.016 0.059 0.050 -0.003 0.065 -0.073 
PostSymmetrySpanTotal -0.171 -0.116 -0.119 0.024 0.068 0.193 
PostSymmetrySpanAbsoluteScore -0.196 -0.074 -0.096 0.007 0.164 0.142 
PostSymmetrySpanSymmetryErrors 0.154 0.178 0.112 0.140 0.048 0.011 
PostSymmetrySpanSpeedErrors 0.234 0.244 0.336 0.268 0.033 -0.148 
PostSymmetrySpanAccuracyErrors 0.069 0.091 -0.022 0.038 0.038 0.076 
EPISODIC 
MEMORY 
PreIFR_WordsWordsRecalled 0.243 0.200 -0.057 0.068 -0.046 0.159 
PostIFR_WordsWordsRecalled 0.153 0.293 0.026 0.123 0.219 0.110 
PreIFR_PicturesWordsRecalled 0.065 0.088 -0.001 0.057 0.040 0.069 
PostIFR_PicturesWordsRecalled -0.022 0.046 -0.061 0.016 0.099 0.103 
PrePairedAssociatesWordsRecalled 0.005 0.060 0.047 0.219 0.082 0.194 
PostPairedAssociatesWordsRecalled -0.049 0.033 -0.080 0.101 0.118 0.229 
PrePairedAssociatesDelayWordsRecalled 0.041 0.104 0.073 0.217 0.097 0.156 
121 
 
 
PostPairedAssociatesDelayWordsRecalled -0.045 0.068 -0.055 0.120 0.164 0.218 
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Table 34. Pearson Correlation Results. NE levels compared to Executive Function and 
Fluid Intelligence Cognitive Performance measures. Red shaded cells indicate positive 
correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. NE was associated with few aspects of Executive 
Function and Fluid Intelligence.
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    NOREPINEPHRINE 
    NE BD1 NE BD7 NE BD2 NE BD8 NE BD2 - BD1 
NE BD8 
- BD7 
    Low Stress High Stress Stress Change 
EXECUTIVE 
FUNCTION 
SDMTB -0.005 -0.023 0.092 0.139 0.094 0.143 
SDMTP -0.058 -0.100 0.051 0.085 0.059 0.098 
PreKeepTrackWordsRecalled -0.131 -0.172 0.020 -0.081 0.038 -0.060 
PreKeepTrackMeanRT 0.036 -0.021 0.112 0.283 0.108 0.290 
PreKeepTrackMeanAccRT 0.035 -0.004 0.076 -0.031 0.073 -0.031 
PostKeepTrackWordsRecalled -0.116 -0.065 0.089 0.029 0.106 0.038 
PostKeepTrackMeanRT -0.046 0.036 0.048 0.229 0.055 0.226 
PostKeepTrackMeanAccRT -0.105 -0.047 -0.054 0.073 -0.040 0.080 
PreStroopCongruousRT 0.008 0.165 -0.060 -0.114 -0.062 -0.137 
PreStroopCongruousAcc 0.067 0.158 -0.137 -0.085 -0.147 -0.107 
PreStroopIncongruousRT 0.006 0.173 -0.147 -0.109 -0.149 -0.133 
PreStroopIncongruousAcc 0.063 -0.004 -0.085 -0.094 -0.094 -0.094 
PreStroopEffect 0.001 0.102 -0.198 -0.051 -0.201 -0.064 
PreStroopCost -0.011 0.122 -0.197 -0.048 -0.198 -0.065 
PreStroopBenefit 0.033 -0.055 -0.007 -0.008 -0.012 -0.001 
PostStroopCongruousRT 0.064 0.153 -0.047 -0.074 -0.056 -0.095 
PostStroopCongruousAcc -0.119 0.054 -0.002 0.089 0.014 0.083 
PostStroopIncongruousRT 0.073 0.228 -0.064 0.028 -0.074 -0.001 
PostStroopIncongruousAcc -0.132 0.017 0.052 0.097 0.070 0.096 
PostStroopEffect 0.057 0.236 -0.061 0.146 -0.070 0.117 
PostStroopCost -0.002 0.170 -0.099 0.114 -0.100 0.093 
PostStroopBenefit 0.167 0.144 0.131 0.063 0.110 0.046 
FLUID 
INTELLIGENCE 
PreNumberSeriesCorrectTrials -0.056 -0.049 0.150 0.071 0.159 0.078 
PreNumberSeriesCorrectTrialRT 0.173 -0.015 0.022 -0.054 -0.001 -0.053 
PostNumberSeriesCorrectTrials -0.060 -0.126 0.069 0.031 0.078 0.047 
PostNumberSeriesCorrectTrialRT 0.121 0.014 0.060 0.077 0.044 0.076 
PreLetterSetsCorrectTrials -0.094 -0.279 0.066 0.012 0.079 0.048 
PreLetterSetsCorrectTrialRT 0.009 0.074 0.076 0.032 0.076 0.023 
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PostLetterSetsCorrectTrials -0.133 -0.135 0.108 0.012 0.127 0.029 
PostLetterSetsCorrectTrialRT  0.021 -0.020 -0.029 0.122 -0.032 0.126 
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Table 35. Pearson Correlation Results. NE levels compared to Working Memory and 
Episodic Memory Cognitive Performance measures. Red shaded cells indicate positive 
correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. NE was associated with few aspects of Working Memory 
but high stress NE was negatively associated with Episodic Memory task scores.
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    NOREPINEPHRINE 
    NE BD1 
NE 
BD7 
NE 
BD2 
NE 
BD8 
NE 
BD2 - 
BD1 
NE 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
WORKING 
MEMORY 
PreRotationSpanTotal 0.010 0.013 0.138 0.097 0.138 0.096 
PreRotationSpanAbsoluteScore 0.019 0.027 0.136 0.082 0.135 0.080 
PreRotationSpanRotationErrors 0.163 0.032 -0.008 -0.035 -0.030 -0.039 
PreRotationSpanSpeedErrors 0.050 0.047 -0.009 0.007 -0.015 0.001 
PreRotationSpanAccuracyErrors 0.267 -0.013 -0.003 -0.088 -0.039 -0.088 
PostRotationSpanTotal 0.068 0.092 0.034 0.169 0.026 0.159 
PostRotationSpanAbsoluteScore 0.030 0.048 0.015 0.155 0.011 0.150 
PostRotationSpanRotationErrors 0.027 -0.090 0.072 -0.029 0.069 -0.017 
PostRotationSpanSpeedErrors 0.037 -0.080 0.023 -0.048 0.019 -0.038 
PostRotationSpanAccuracyErrors -0.020 -0.058 0.160 0.045 0.164 0.053 
PreSymmetrySpanTotal -0.035 -0.095 0.001 -0.091 0.006 -0.080 
PreSymmetrySpanAbsoluteScore -0.013 -0.061 -0.012 -0.047 -0.010 -0.039 
PreSymmetrySpanSymmetryErrors -0.067 0.047 -0.130 -0.080 -0.122 -0.087 
PreSymmetrySpanSpeedErrors 0.060 0.077 -0.095 -0.060 -0.104 -0.070 
PreSymmetrySpanAccuracyErrors -0.093 0.024 -0.107 -0.065 -0.095 -0.069 
PostSymmetrySpanTotal 0.081 -0.025 0.095 0.039 0.085 0.043 
PostSymmetrySpanAbsoluteScore 0.077 0.003 0.179 0.058 0.170 0.058 
PostSymmetrySpanSymmetryErrors -0.117 0.041 -0.095 0.001 -0.080 -0.005 
PostSymmetrySpanSpeedErrors -0.175 -0.098 -0.055 -0.100 -0.032 -0.089 
PostSymmetrySpanAccuracyErrors -0.043 0.096 -0.080 0.052 -0.075 0.040 
EPISODIC 
MEMORY 
PreIFR_WordsWordsRecalled -0.065 -0.025 -0.075 -0.030 -0.067 -0.027 
PostIFR_WordsWordsRecalled -0.086 -0.043 -0.001 -0.026 0.011 -0.021 
PreIFR_PicturesWordsRecalled -0.210 -0.110 -0.137 -0.065 -0.110 -0.051 
PostIFR_PicturesWordsRecalled -0.108 -0.070 -0.075 -0.005 -0.061 0.004 
PrePairedAssociatesWordsRecalled -0.100 -0.224 -0.253 -0.169 -0.242 -0.142 
PostPairedAssociatesWordsRecalled -0.034 -0.083 -0.129 -0.102 -0.126 -0.093 
PrePairedAssociatesDelayWordsRecalled -0.061 -0.102 -0.228 -0.218 -0.223 -0.207 
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PostPairedAssociatesDelayWordsRecalled -0.027 -0.116 -0.135 -0.033 -0.133 -0.018 
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Table 36. Pearson Correlation Results. NPY levels compared to Executive Function and 
Fluid Intelligence Cognitive Performance measures. Red shaded cells indicate positive 
correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. High stress NPY was positively correlated with some 
aspects the Keep Track Executive Function tasks and the Letter Sets Fluid Intelligence 
tasks.
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  NPY 
    NPY NPY BD7 
NPY 
BD2 
NPY 
BD8 
NPY 
BD2 - 
BD1 
NPY 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
EXECUTIVE 
FUNCTION 
SDMTB -0.015 -0.056 0.004 -0.010 0.005 -0.008 
SDMTP -0.064 -0.107 0.012 0.014 0.015 0.019 
PreKeepTrackWordsRecalled 0.126 0.079 .209 .223 .204 .222 
PreKeepTrackMeanRT -0.153 -0.129 .215 0.105 .225 0.111 
PreKeepTrackMeanAccRT 0.023 0.058 -0.089 -0.076 -0.091 -0.079 
PostKeepTrackWordsRecalled .176 .204 0.155 .212 0.148 .206 
PostKeepTrackMeanRT -0.032 -0.134 0.127 0.042 0.129 0.048 
PostKeepTrackMeanAccRT 0.059 0.062 0.063 0.075 0.061 0.073 
PreStroopCongruousRT -0.063 0.052 -0.093 -0.161 -0.090 -0.164 
PreStroopCongruousAcc 0.020 0.042 -0.023 -0.164 -0.025 -0.167 
PreStroopIncongruousRT -0.045 0.014 -0.069 -0.174 -0.067 -.176 
PreStroopIncongruousAcc .220 0.109 -0.016 -0.111 -0.028 -0.116 
PreStroopEffect 0.000 -0.046 -0.004 -0.111 -0.004 -0.110 
PreStroopCost 0.010 -0.049 0.021 -0.102 0.021 -0.101 
PreStroopBenefit -0.029 0.007 -0.073 -0.029 -0.072 -0.029 
PostStroopCongruousRT -.179 0.000 -0.087 -0.120 -0.079 -0.121 
PostStroopCongruousAcc -0.039 0.022 0.055 0.030 0.057 0.030 
PostStroopIncongruousRT -0.135 0.019 -0.020 -0.068 -0.013 -0.070 
PostStroopIncongruousAcc 0.001 0.064 0.054 0.031 0.054 0.028 
PostStroopEffect -0.026 0.035 0.072 0.023 0.074 0.022 
PostStroopCost -0.045 0.021 0.086 0.061 0.090 0.061 
PostStroopBenefit 0.064 0.035 -0.061 -0.123 -0.065 -0.126 
FLUID 
INTELLIGENCE 
PreNumberSeriesCorrectTrials 0.077 0.079 0.093 .194 0.089 .192 
PreNumberSeriesCorrectTrialRT -0.029 -0.054 0.068 0.111 0.071 0.114 
PostNumberSeriesCorrectTrials 0.014 0.070 0.084 .187 0.084 .185 
PostNumberSeriesCorrectTrialRT -0.030 0.029 -0.007 -0.132 -0.006 -0.134 
PreLetterSetsCorrectTrials -0.028 0.039 -0.086 0.033 -0.086 0.032 
130 
 
 
PreLetterSetsCorrectTrialRT -0.024 0.099 .247 0.040 .250 0.036 
PostLetterSetsCorrectTrials 0.058 0.086 0.142 .216 0.140 .215 
PostLetterSetsCorrectTrialRT 0.044 0.158 0.006 0.064 0.004 0.058 
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Table 37. Pearson Correlation Results. NPY levels compared to Working Memory and 
Episodic Memory Cognitive Performance measures. Red shaded cells indicate positive 
correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. High Stress NPY was positively correlated with the 
Symmetry Span Executive Function task scores but not associated with Episodic 
Memory.
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    NPY 
    NPY BD1 
NPY 
BD7 
NPY 
BD2 
NPY 
BD8 
NPY 
BD2 - 
BD1 
NPY 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
WORKING 
MEMORY 
PreRotationSpanTotal 0.086 0.005 0.123 .193 0.120 .194 
PreRotationSpanAbsoluteScore 0.039 0.004 0.123 0.136 0.123 0.137 
PreRotationSpanRotationErrors -0.161 -.227 -0.085 -0.075 -0.077 -0.066 
PreRotationSpanSpeedErrors -0.136 -.270 -0.088 -0.114 -0.082 -0.104 
PreRotationSpanAccuracyErrors -0.110 -0.017 -0.028 0.039 -0.023 0.040 
PostRotationSpanTotal 0.011 0.046 0.141 .203 0.142 .202 
PostRotationSpanAbsoluteScore -0.006 0.036 0.010 0.130 0.010 0.130 
PostRotationSpanRotationErrors -0.121 -0.161 -0.023 -0.068 -0.017 -0.062 
PostRotationSpanSpeedErrors -0.133 -.184 -0.078 -0.136 -0.072 -0.130 
PostRotationSpanAccuracyErrors -0.008 0.013 0.147 0.169 0.149 0.170 
PreSymmetrySpanTotal 0.079 0.131 0.073 0.155 0.069 0.151 
PreSymmetrySpanAbsoluteScore 0.111 0.041 0.067 0.143 0.062 0.142 
PreSymmetrySpanSymmetryErrors 0.157 0.053 -0.048 -0.125 -0.056 -0.129 
PreSymmetrySpanSpeedErrors .206 .211 0.117 0.057 0.107 0.049 
PreSymmetrySpanAccuracyErrors 0.098 -0.016 -0.091 -0.154 -0.097 -0.155 
PostSymmetrySpanTotal 0.113 0.109 .235 .233 .232 .231 
PostSymmetrySpanAbsoluteScore 0.089 0.054 .233 .209 .231 .208 
PostSymmetrySpanSymmetryErrors -0.060 -0.071 -0.164 -.203 -0.162 -.202 
PostSymmetrySpanSpeedErrors 0.020 0.040 -0.020 0.014 -0.021 0.012 
PostSymmetrySpanAccuracyErrors -0.079 -0.101 -.176* -.238 -.174 -.236 
EPISODIC 
MEMORY 
PreIFR_WordsWordsRecalled -0.062 -0.075 -0.037 -0.027 -0.035 -0.024 
PostIFR_WordsWordsRecalled 0.037 -0.031 0.002 0.165 0.000 0.168 
PreIFR_PicturesWordsRecalled -0.076 -0.005 0.118 0.054 0.123 0.055 
PostIFR_PicturesWordsRecalled -0.093 -0.050 0.072 -0.008 0.077 -0.006 
PrePairedAssociatesWordsRecalled -0.039 -0.043 0.002 -0.054 0.004 -0.053 
PostPairedAssociatesWordsRecalled -0.014 0.025 0.174 .188 .176 .188 
PrePairedAssociates_DelayWordsRecalled 0.011 -0.015 -0.021 -0.004 -0.022 -0.003 
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PostPairedAssociates_DelayWordsRecalled -0.027 -0.010 0.169 0.170 0.171 0.171 
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Table 38. Pearson Correlation Results. Serotonin levels compared to Executive Function 
and Fluid Intelligence Cognitive Performance measures. Red shaded cells indicate 
positive correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. Serotonin was associated with few aspects of Executive 
Function and Fluid Intelligence.
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    SEROTONIN 
    SERO BD1 
SERO 
BD7 
SERO 
BD2 
SERO 
BD8 
SERO 
BD2 - 
BD1 
SERO 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
EXECUTIVE 
FUNCTION 
SDMTB 0.103 -0.021 0.150 0.070 0.102 0.122 
SDMTP 0.135 0.103 .196 0.140 0.133 0.076 
PreKeepTrackWordsRecalled -0.063 -0.047 -0.007 0.001 0.062 0.057 
PreKeepTrackMeanRT 0.053 0.106 -0.049 -0.083 -0.136 -.238 
PreKeepTrackMeanAccRT -0.106 -0.012 -0.087 -0.058 -0.009 -0.065 
PostKeepTrackWordsRecalled -0.054 0.042 0.041 0.109 0.117 0.104 
PostKeepTrackMeanRT -0.005 0.057 -0.015 -0.139 -0.016 -.265 
PostKeepTrackMeanAccRT -0.062 -0.005 -0.030 -0.039 0.024 -0.048 
PreStroopCongruousRT -0.109 -0.081 -0.146 -0.170 -0.089 -0.142 
PreStroopCongruousAcc -0.007 -0.069 -0.077 -0.111 -0.106 -0.073 
PreStroopIncongruousRT -0.087 -0.093 -0.129 -0.143 -0.088 -0.091 
PreStroopIncongruousAcc 0.032 -0.102 -0.065 -0.151 -0.136 -0.090 
PreStroopEffect -0.017 -0.065 -0.044 -0.040 -0.046 0.023 
PreStroopCost -0.016 -0.051 -0.052 -0.057 -0.058 -0.018 
PreStroopBenefit -0.001 -0.042 0.021 0.048 0.033 0.120 
PostStroopCongruousRT 0.024 0.028 -0.116 -0.058 -.193 -0.115 
PostStroopCongruousAcc 0.022 0.043 0.051 0.021 0.048 -0.022 
PostStroopIncongruousRT 0.012 0.014 -0.072 -0.072 -0.117 -0.118 
PostStroopIncongruousAcc -0.037 -0.023 -0.008 -0.072 0.029 -0.075 
PostStroopEffect -0.008 -0.009 0.011 -0.062 0.024 -0.077 
PostStroopCost -0.022 -0.014 -0.034 -0.044 -0.024 -0.046 
PostStroopBenefit 0.046 0.016 0.134 -0.039 0.142 -0.075 
FLUID 
INTELLIGENCE 
PreNumberSeriesCorrectTrials 0.123 0.032 0.101 0.070 0.009 0.058 
PreNumberSeriesCorrectTrialRT 0.013 -0.047 -0.026 0.005 -0.054 0.062 
PostNumberSeriesCorrectTrials 0.120 0.096 0.087 0.082 -0.006 0.001 
PostNumberSeriesCorrectTrialRT 0.015 0.000 -0.012 -0.037 -0.033 -0.052 
PreLetterSetsCorrectTrials 0.034 0.018 0.019 0.073 -0.011 0.078 
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PreLetterSetsCorrectTrialRT -0.024 0.061 -0.035 -0.086 -0.025 -.189 
PostLetterSetsCorrectTrials -0.040 0.031 -0.007 0.048 0.033 0.031 
PostLetterSetsCorrectTrialRT -0.040 -0.079 -0.017 -0.105 0.019 -0.054 
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Table 39. Pearson Correlation Results. Serotonin levels compared to Working Memory 
and Episodic Memory Cognitive Performance measures. Red shaded cells indicate 
positive correlations and blue shaded cells indicate negative correlations. Darker shading 
represents stronger association. Serotonin was associated with few aspects of Working 
Memory and Episodic Memory. 
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    SEROTONIN 
    SERO BD1 
SERO 
BD7 
SERO 
BD2 
SERO 
BD8 
SERO 
BD2 - 
BD1 
SERO 
BD8 - 
BD7 
    Low Stress High Stress Stress Change 
WORKING 
MEMORY 
PreRotationSpanTotal 0.064 -0.065 0.037 0.041 -0.018 0.133 
PreRotationSpanAbsoluteScore 0.084 0.015 0.056 0.098 -0.013 0.117 
PreRotationSpanRotationErrors -0.072 -0.019 0.021 0.035 0.115 0.071 
PreRotationSpanSpeedErrors -0.054 -0.045 0.008 0.019 0.075 0.079 
PreRotationSpanAccuracyErrors -0.062 0.039 0.031 0.043 0.118 0.013 
PostRotationSpanTotal 0.118 0.071 0.036 0.105 -0.077 0.064 
PostRotationSpanAbsoluteScore 0.061 0.021 -0.005 0.135 -0.074 0.165 
PostRotationSpanRotationErrors -0.001 -0.037 0.074 0.063 0.107 0.133 
PostRotationSpanSpeedErrors 0.010 -0.018 0.069 0.052 0.087 0.095 
PostRotationSpanAccuracyErrors -0.032 -0.067 0.039 0.051 0.090 0.152 
PreSymmetrySpanTotal 0.059 0.010 0.089 0.059 0.066 0.068 
PreSymmetrySpanAbsoluteScore 0.114 0.022 0.162 0.119 0.113 0.137 
PreSymmetrySpanSymmetryErrors -0.133 -0.105 -0.124 -0.176 -0.033 -0.119 
PreSymmetrySpanSpeedErrors -0.054 -0.075 -0.059 -0.085 -0.026 -0.028 
PreSymmetrySpanAccuracyErrors -0.124 -0.087 -0.113 -0.160 -0.027 -0.118 
PostSymmetrySpanTotal 0.041 0.048 0.100 0.054 0.099 0.019 
PostSymmetrySpanAbsoluteScore 0.048 0.061 0.154 0.103 0.168 0.073 
PostSymmetrySpanSymmetryErrors -0.059 -0.114 -0.111 -0.178 -0.095 -0.116 
PostSymmetrySpanSpeedErrors -0.022 0.013 0.056 0.017 0.104 0.009 
PostSymmetrySpanAccuracyErrors -0.056 -0.137 -0.155 -0.211 -0.161 -0.136 
EPISODIC 
MEMORY 
PreIFR_WordsWordsRecalled 0.147 0.150 0.080 0.168 -0.051 0.057 
PostIFR_WordsWordsRecalled -0.058 0.037 -0.023 0.085 0.030 0.076 
PreIFR_PicturesWordsRecalled -0.058 -0.030 -0.073 -0.070 -0.042 -0.062 
PostIFR_PicturesWordsRecalled -0.097 0.019 0.012 0.037 0.124 0.030 
PrePairedAssociatesWordsRecalled -0.059 -0.091 -0.038 -0.002 0.012 0.110 
PostPairedAssociatesWordsRecalled -0.019 0.060 0.049 0.108 0.090 0.081 
PrePairedAssociatesDelayWordsRecalled -0.055 -0.083 -0.013 0.007 0.044 0.115 
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PostPairedAssociatesDelayWordsRecalled 0.070 0.055 0.100 0.122 0.070 0.117 
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DISCUSSION 
The purpose of this study was to evaluate the biomarker signatures of stress and 
resilience and their relationships with performance over the course of a 12-week nutrition 
and exercise intervention in a healthy AF population. Our findings indicate that these 
interventions had mixed effects on the chosen biomarkers despite clear significant 
increases in physical performance and some increases in cognitive performance. Our 
results also show that specific biomarkers were associated with certain aspects of these 
performance measures. Though our population consisted of healthy, active duty AF 
members, they exhibited a wide range of physiological differences. This suggests that the 
benefits of exercise and nutrition interventions may be more effective when tailored to 
the individual subject’s physiology. 
Aim 1a. – Exercise Intervention 
The Exercise Intervention influenced changes in two of the biomarker measures. 
The exercise intervention significantly reduced subjects’ resting NPY levels and reduced 
subjects’ peak cortisol levels and their cortisol response to stress (Table 7). No other 
biomarkers were affected. 
One of the two significant biomarker changes resulting from the 12-week exercise 
intervention was decreased low stress (baseline) NPY levels (Table 7). However, the 
Bonferroni multiple comparison procedure showed that the significance difference 
occurred within the training intervention; the pre-to-post levels (Week 1 to Week 14) 
were not significantly different (Table 9). This suggests that the intervention did not 
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confer lasting change. While not statistically significant, we also observed a trend that 
high stress levels of NPY and the change from low to high stress levels of NPY both 
increased with exercise training (p=.080, p=.060, respectively) (Table 7). Though NPY is 
considered a marker of stress resilience, it is important to consider the conditions under 
which it is measured. Higher levels of NPY released under stress confer performance 
benefit (Lieberman, 2016; Morgan, 2000; Morgan 2002). Baseline levels, however, are 
not well understood. High resting levels are associated with insulin resistance, obesity 
(Kuo et al. 2007), and atherosclerosis (Li et al. 2003), but lowered resting levels are 
associated with trauma exposure (Morgan, 2003). It is therefore unclear what role 
baseline NPY levels play. Our correlation analysis shows no association between low 
stress NPY levels and physical or cognitive performance, but high stress NPY levels are 
positively associated with better agility, core endurance, and muscle endurance scores, as 
well as lower body fat percentage. This evidence suggests that stress-induced NPY 
release is a more accurate biomarker of performance than resting NPY measures.   
The second significant biomarker change resulting from the 12-week exercise 
intervention was a reduced cortisol response to the VO2 Max challenge (Table 7). This 
was not unexpected, as studies have shown reduced cortisol response to stress after 
exercise training interventions (Kraemer, 1999). Rimmele, et al. 2007 showed trained vs. 
untrained subjects have a reduced cortisol response to a psychosocial stressor. Subjects’ 
reduced cortisol response to stress may also be due to a conditioning response. Our 
lengthy pre-testing battery of measurements, blood draws, tests, and surveys is a multi-
faceted stressor in itself. By post-testing, subjects are familiar with the lab environment, 
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the tests, and the experimenters, thus we would expect to see a decrease in their cortisol 
response as a result of repeat exposure. 
Aim 1b. – Nutritional Intervention 
The Nutritional Intervention yielded one significant biomarker change: decreased 
high stress NE levels (Table 8). These changes were only observed in the High Nutrient 
group, while the Low Nutrient Group levels increased, suggesting that the experimental 
supplement affected the NE stress response (Figure 3). These findings support the data 
from Hamazaki, 2000, who found that DHA supplementation reduced plasma NE levels 
in students during a 2 month final exam period. However, the type of stress the subjects 
experienced was different. Additional research will be needed to confirm that DHA 
reduces peak NE levels caused by an acute physical stressor. 
As noted, we observed changes in some, but not all biomarker signatures over the 
course of the interventions. For example, subjects’ cortisol response was attenuated post-
intervention, but their low stress (baseline) cortisol levels did not significantly change. 
Past research shows mixed results regarding changes in cortisol levels after exercise 
intervention. While Kraemer et al. 1999 found decreased levels in healthy adult resting 
cortisol post 10 week exercise intervention, this change was only significant in the older 
subset of participants. Our findings suggest that exercise interventions have a greater 
effect on the release of cortisol in response to acute stress compared to resting levels. 
Other biomarker levels, such as serotonin, were not affected by either intervention. This 
study is the first to examine changes in peripheral serotonin resulting from 
supplementation and exercise. 
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Another explanation for the limited biomarker changes could be a benefit plateau 
effect. Our population is markedly different from the general population. Active Duty AF 
members are on average healthier than the general population – they are required to pass 
a physical fitness test each year, they have lower rates of obesity, and they have 
guaranteed access to medical care, including preventative care (Eilerman et al., 2014). 
They also exhibit lower stress biomarker levels and higher resilience biomarker levels 
(Shia et al., 2015). Though our study population was only slightly more fit than that of 
the AF population overall – 17.7% of our subjects had >30.0 Body Mass Index score 
compared to 18.9% of the AF at large (Eilerman et al., 2014), our population was also 
highly motivated. They not only volunteered themselves for a 14-week intervention with 
daily involvement, but by removing any subjects that had <80% participation, we 
naturally selected the most motivated within that subgroup. Because our population was 
already healthy, highly motivated, and have more ideal biomarker signatures, they may 
require a longer or more intense (Yerkes-Dodson, 1908) intervention period before wide-
ranging changes in stress and resilience markers occur. The benefits of diet and exercise 
may have diminishing returns.  
Aim 2. - Biomarker-Performance Associations 
We sought to assess the relationships between biomarkers of stress and resilience 
and physical and cognitive performance measures. The Pearson correlation analysis 
illuminated several points.  
First, we found that biomarker levels released under high stress conditions were 
more tightly correlated with physical performance than those under low stress conditions 
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(Tables 10-25). This was not unexpected, as the performance measures are themselves 
high stress conditions. The only exception to this was serotonin – low stress levels were 
more correlated to performance than high stress levels, though not strongly (Table 28). 
Serotonin functions in part to regulate peripheral vascular tone (Rapport, 1948) and in 
control of breathing during exercise (Bach, 1993) which may explain the correlations we 
see with anaerobic performance, that is, increased serotonin availability may better 
regulate blood pressure and increase the drive to breathe during exercise. These 
correlations also mark serotonin as a potential predictor of physical performance. This is 
critical for application, as biomarkers are more useful if their resting levels are indicative 
of future performance.  
Second, certain biomarkers were associated with specific aspects of performance. 
For example, we observed positive relationships between high stress NPY and agility, 
muscle endurance, core endurance, and aerobic power scores (Table 23). Peripheral NPY 
is secreted upon SNS activation and acts as a blood pressure regulator. Exercise increases 
skeletal muscle blood flow by way of arterial dilation, and NPY acts as a vasoconstrictor 
to balance this effect in order to maintain adequate arterial pressure and flow (Holwerda, 
2015). This mechanism may explain why NPY levels positively correlate with physical 
performance. The more NPY secreted during exercise may better regulate and maintain 
blood pressure and flow during the task, aiding in physical performance. 
Third, though strong relationships were seen between biomarkers and physical 
performance, their relationships with cognitive performance were weaker (Tables 30-39). 
This was not unexpected, as all biomarkers were measured peripherally and only cortisol 
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and unsulfated-DHEA easily cross the BBB to exert central effects. Despite weaker 
relationships, some patterns emerged. Cortisol and DHEA-S had more correlations with 
cognitive performance than the other biomarkers, and these correlations tended to be 
negative with respect to cortisol and positive with respect to DHEA-S. This pattern can 
be seen in the Working Memory and Episodic Memory tasks (Table 31 and Table 33). 
This supports existing data from Vaz, 2011 which showed that increased cortisol levels 
are connected with poorer working memory. Similarly, Alhaj, 2006, showed that DHEA 
levels are associated with better episodic memory, though they did not also measure 
DHEA-S levels.  
Not all biomarker-performance relationships were maintained after the 
interventions. Pre-testing cortisol response was positively associated with muscle 
endurance, agility, aerobic power, anaerobic power, and balance, but post-testing cortisol 
response was not (Table 12, Table 13). This pattern was also observed in NE for muscle 
endurance, agility, aerobic power, and anaerobic power (Table 19, Table 20). If the levels 
of stress biomarkers were simply elevated during pre-testing due to the stress of 
unfamiliarity, we would not expect the levels to then be correlated with performance 
measures. This suggests that untrained individuals may gain performance benefit from 
higher cortisol and NE responses, while trained individuals do not. This is supported by 
the data from Rimmele, 2007 and Bloom, 1976. Elevated release of cortisol and NE 
under stress may be a compensatory mechanism for lack of physical fitness. 
While we found associations between biomarkers and performance, it is important 
to not overlook simpler measures that may have correlations of equal or greater strength. 
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Lean Muscle Mass (LMM), for example, was more tightly correlated with our physical 
performance measures than any of the five chosen biomarkers. This may call into 
question the utility of these biomarkers. Though LMM is a better predictor of the 
straightforward performance criteria measured in this study (push-ups, sit-ups, pull-ups, 
etc.) it may be less effective when predicting more complex performance tasks like 
underwater navigation (Morgan, 2009) or mock captivity and interrogation (Morgan, 
2002). Additionally, when studying less diverse populations in which subjects have 
similar body compositions (Special Forces, etc.), biomarkers of stress and resilience may 
be the key differentiating factors between high and low performers. To apply biomarkers 
for the assessment of performance, it is necessary first to carefully consider the type and 
context of the task and the physiology of the participants. 
The magnitude of the Pearson correlation coefficient (R) indicates strength of 
relationship, with the strength increasing further from 0. The R2 value indicates amount 
of variance explained in Y by X. For example, the R2 for high stress cortisol and agility 
score is -0.3642 = .1325, meaning that 13.25% of the variance in agility scores is 
explained by cortisol. However, even a strong relationship does not imply cause and 
effect. Controlling for confounding variables known to affect biomarker levels was 
performed, but there may be additional unknown factors influencing biomarker levels. 
For this reason, we must cautiously interpret and apply these results. Rather than directly 
attributing performance changes to biomarker levels, these correlation data may be more 
appropriately used to identify which biomarkers to monitor for more complex tasks that 
combine multiple aspects of physical and cognitive performance, or as a starting point to 
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further investigate the mechanisms by which these biomarkers may influence 
performance change. 
Clinical Relevance 
Though statistically significant, the observed biomarker changes may not be 
clinically relevant for our population. The pre- and post-testing baseline values for both 
NPY and DHEA-S, for example, were within normal ranges (Khatun, 2000; Salek, 2002). 
Active Duty Airmen generally exhibit lower stress biomarker levels and higher resilience 
biomarker levels compared to volunteer firefighters (Shia et al., 2015). Reducing stress 
biomarker levels already within normal ranges may not confer meaningful health benefit. 
Likewise, raising levels of resilience markers that are already at the optimal end of the 
healthy range may not prove beneficial until an individual experiences extreme stress. 
However, the future applications of these results are intended also for deployed 
populations, elite forces, and other groups that are more likely to face severe, long-term, 
and/or compounded stress. Therefore, the statistically significant results gained from this 
study may not become biologically meaningful until they are applied to populations 
under circumstances of extreme stress. 
Limitations 
This study has several limitations which should be considered. Due to the 
logistics of testing our subjects in the limited time allotted, subjects’ blood was not drawn 
at the same time of day. To account for this, the time of day was recorded for each draw 
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and was factored in as a covariate during statistical analysis for cortisol, which exhibits 
diurnal fluctuation. 
While it has been demonstrated that the chosen biomarkers are associated with 
stress and performance, there exist other markers that also reflect stress-related outcomes 
such as IL-1, IL-6, C-reactive protein, β-NGF, and testosterone. Nutritional biomarkers 
may also be useful for tracking health during supplementation interventions. Current 
technology only allows for a snapshot of a subject’s physiology. Until we have the ability 
to perform comprehensive, real-time biomarker tracking, additional markers should be 
monitored to better grasp the changes occurring in participants’ physiology. For future 
research, a large biomarker panel may be more appropriate for assessing biomarker 
changes over time and their relationships with performance. 
Despite fairly stringent exclusion criteria, our population was not as homogenous 
as anticipated. Even though our population was a healthier subset of the general 
population, our subjects still exhibited a wide berth of physiological differences. For 
example, subjects’ initial body fat percentages ranged from 12.9% - 48.5%, subjects’ 
initial lean muscle mass weight ranged from 77.4 – 189.6 lbs, and subjects’ initial VO2 
Max scores ranged from 24.9 – 79.3 mL/kg/min. Despite these differences, all subjects 
underwent the same training regimen and were given one of two supplement formulas. 
Individualization of the interventions may have improved performance and biomarker 
signatures more effectively. Future studies that target performance may benefit by 
focusing on the needs of the individual, taking into account age, gender, weight/BMI, 
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total daily energy expenditure (TDEE), specific dietary needs, and using targeted exercise 
strategies to enhance areas of weakness or limitation.  
Subjects’ diets were not controlled in this study. Subjects were expected to self-
adjust their caloric intake to account for the additional calories of the supplement, but this 
was not specifically tracked. To offset these variables, participants were asked to take a 
once weekly survey (DNI) to assess dietary intake, sleeping habits, alcohol consumption, 
and nicotine use. Though these data were largely qualitative, they were analyzed by a 
registered dietician and no significant differences were found between the two groups. 
Nutritional supplementation studies, particularly those researching multivitamins, 
have shown mixed results (Brown, 2017). One general consensus in this field is that 
supplements are effective if the person is deficient in the nutrient being supplemented 
(Blumberg, et al., 2018). Because our supplement contains ingredients that can be 
obtained through diet, it is possible that we observed few significant changes in the 
experimental group due to a lack of initial nutrient deficiency in our participants. Though 
subjects’ general eating habits were evaluated with the DNI survey, quantitative 
nutritional analysis data was not obtained. We do know that few of our subjects ate fish 
regularly, but we do not know the levels of omega-3 fatty acids in their blood to 
determine adequacy or deficiency, for example. Future studies would benefit by adding 
this analysis in order to more accurately ascribe changes to the nutritional supplement 
itself and not an unknown outside factor. 
Similarly, this study also lacked a nutrient absorption analysis. To decipher 
whether or not changes are occurring due to the nutritional supplement, it is first 
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important to know that the ingredients in the supplement are being absorbed by the body 
and not simply ingested and excreted. Knowing the pre and post serum levels of key 
nutritional markers (in our case, lutein, DHA, phospholipids, and Ca-HMB) will also 
allow us parse which of these ingredients may be responsible for changes.  
Though this study included a placebo group, it did not include a sham group with 
subjects who took the placebo supplement but did not participate in the exercise 
intervention or a group with subjects that did not participate in either. As such, we cannot 
rule out any effects of time alone on biomarker changes. As mentioned previously, repeat 
exposure to the testing protocols also may have resulted in a conditioning effect that is 
responsible or partly responsible for the observed within-group changes. 
Lessons Learned - Logistics of Longitudinal Biomarker Studies 
Tracking biomarkers over multiple years presents unique logistical challenges. 
Even stored at or below -20 degrees F, degradation of sample analytes occurs (Dörner & 
Böhler, 1996; Koch & Platoff, 1990; Zhang et al., 1998). To minimize this effect, each 
cohort’s blood samples were tested after the completion of their respective intervention 
cycle. However, this produced another logistical challenge. Assay kits ordered more than 
a few months apart may not be of the same lot production, and therefore may introduce 
significant variability among the cohorts. Our dataset initially showed this type of 
variability. To mitigate this, representative samples from multiple cohorts were assayed 
on the same plate to check for consistency. Cohorts with representative samples 
significantly different from the original assay results were rerun entirely. For future 
studies, a potential solutions for these issues are as follows: 
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1) Depending on the stability of the analytes, all samples may be assayed at the 
conclusion of the study and therefore all within the same assay lot, and a 
correction factor(s) may be applied to account for each analyte’s rate of 
degradation. This method assumes samples do not degrade entirely and that rates 
of decay are well-established. 
2) Samples may be analyzed after each cohort as was done here, but with the added 
cooperation of assay production companies to reserve enough kits within the same 
lot to cover the estimated final sample count. This method is costly (more kits 
must be purchased to cover the higher end of the final subject count estimate) and 
depending on the length of the study, the kits may expire prior to completion.
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CONCLUSIONS 
This is one of the first studies to examine the role of an innovative nutritional 
supplement with mandatory exercise training for the enhancement of physical and 
cognitive function in active duty AF personnel. More specifically, we were able to test 
for the first time in humans whether this intervention strategy moderates stress and 
resilience biomarker levels with respect to cognitive and physical performance. Active 
duty military, especially those deployed, face increased levels of stress that put them at 
risk for impaired performance (Booth-Kewley 2010). It is therefore imperative that the 
AF to develop non-invasive strategies to enhance airmen resilience and optimize 
readiness. This study presented evidence that this nutrition and exercise intervention can 
reduce the cortisol stress response and decrease peak stress cortisol and NE levels. These 
changes, however, were modest and may not be clinically relevant. This study also 
showed presented evidence that suggests stress-induced biomarker release is generally a 
more accurate predictor of physical performance than resting measures, and that many of 
these biomarker measures are correlated with specific aspects of physical and cognitive 
performance. 
For future research, we recommend that these diet and exercise strategies be 
tailored to the individual’s needs for greater efficacy. To more accurately assess changes 
occurring due to these strategies, we recommend that additional control and sham groups 
be included, that nutrient absorption analysis of supplements be performed, that 
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additional biomarkers of stress, resilience, and inflammation be measured, and that care 
is taken to analyze these markers under the appropriate conditions. 
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APPENDIX 
Demographic & Medical Screening Questionnaire 
 
NOTE: Please complete this form accurately and honestly. This is in your best interest, as it will 
help reduce injury risk exposure that is associated with your participation in this study.  
 
Subject ID_____________________ Age__________ Date____________ 
 
Handedness:________________________________________________________________________ 
 
Highest education level completed: _____________________________________________________ 
 
Estimated GPA at highest education level: ________________________________________________ 
 
If you are currently attending school, please indicate your current status:________________________ 
 
__________________________________________________________________________________ 
 
If you attended college, what was your major: _____________________________________________ 
 
Years of military service: ______________________________________________________________ 
 
Current military rank: _________________________________________________________________ 
 
Current military career field: ____________________________________________________________ 
 
Are you currently on a medical or pregnancy profile?  YES/NO  
 
Are you currently taking a multivitamin? YES/NO 
If so, please  list and/or describe: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Are you currently taking alertness altering medications? YES/NO 
If so, please  list and/or describe: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Are you currently taking antibiotics or blood thinners such as aspirin? YES/NO 
If so, please  list and/or describe: 
_____________________________________________________________________________________
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_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Are you currently taking nutritional supplements for physical fitness? YES/NO 
If so, please  list and/or describe: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Do you smoke regularly? YES/NO 
If yes, how often: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Do you regularly drink alcohol? YES/NO 
If yes, how often: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Do you experience fainting spells? YES/NO 
If yes, how often: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
 
Do you have a family history of early cardiac death? YES/NO 
If yes, please describe: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Have you recently been diagnosed with high/low blood pressure, a cardiac illness, or high cholesterol? 
YES/NO 
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If yes, please describe when: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
 
Do you have a history of asthma or other respiratory problems? YES/NO 
If yes, how often: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Have you experienced black-outs or bouts of dizziness during high physical exertion? YES/NO 
If yes, how often: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Do you currently experience, and/or are you being treated by a medical provider (e.g., MD, physical 
therapist, chiropractor etc.), for any of the following: Infection, anemia, diabetes, allergic reaction to 
adhesives/tape, Urticaria (hives), atopy, swelling, musculoskeletal pain/injury (including back or joint 
pain), sleep disturbances, stroke or TIA (temporary stroke)  
 
 If yes, please explain: 
 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
Have you ever experienced any other serious medical illness or injury other than those mentioned in the 
previous questions? 
If yes, please explain: 
 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
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Have you experienced, or are you currently experiencing, any medical symptoms or complaints (e.g., 
back pain, joint pain, headaches, persistent nausea, etc.) that have not been evaluated by a medical 
provider? 
If yes, please explain: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
  
Are you recovering from a recent surgery in the past 2 years? YES/NO 
 
If yes, please explain: 
 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
________________________ 
 
 
Do you exercise?  Yes/No 
 
What activity/activities? _____________________________________ 
How long have you been exercising? ____________________________________________ 
How many days per week do you exercise? ____________________ 
How many minutes per day? _________________________ 
What kind of shoes do you wear when working out? _________________________________________ 
Have you ever worn physiological monitor (Polar heart rate monitor) while exercising?_____________ 
Do you count your pulse during your workout? _________________ 
 
What is a typical 24 hour for yourself?  
_______________ Work     _______________ TV 
_______________ Relaxation    _______________ Driving/Riding 
_______________ Eating    _______________ Exercise 
_______________ Sleep 
 
 
 
CLEARED/NOT CLEARED FOR RESEARCH PARTICIPATION 
 
 
______________________________________________________________________________
MEDICAL OBSERVER SIGNATURE/DATE  
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Life Stress Questionnaire 
 
Subject ID                 
         
Date                 
         
IN THE LAST 12 MONTHS:  Listed below are a number of events which sometimes bring about change in the lives of those 
who experience them. Please CHECK either YES or NO to indicate whether YOU, or if indicated, your mate, spouse, close friend 
or family member have experienced the event in the past 12 months. FOR THE EVENTS YOU CHECK "YES", please indicate 
whether you viewed the event as having either a BAD or Good impact on YOUR life at the time the event occurred, regardless of 
what may have eventually happened as a result of the event. Whether the event happened to you or someone important in your life, 
please indicate whether it had a BAD or Good impact on YOUR Life when it happened. Also for the events you circled "YES," 
indicate how stressful the event was at the time the event occurred.          
SCHOOL 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
  YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
1. Started or changed 
school or training program? 
                
2. Graduated from school 
or training program? 
                
3. Had significant added 
responsibility at school? 
                
4. Had significant problems 
in school or training 
program? 
                
WORK 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
  YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
5. Started regular work for 
the first time? 
                
6. Returned to work after 
not working for a long 
time? 
                
7. Looked for but could not 
find employment? 
                
8. Retired?                 
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9. Changed jobs?                 
10. Had trouble with a 
boss? 
                
11. Laid off or fired.                 
12. Stopped work or quit.                 
13. Took on a greatly 
increased workload? 
                
LOVE 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
14. Separated from mate 
for more than two weeks 
due to an argument or 
discord? 
                
15. Got a divorce?                 
16. Started dating after not 
dating for a long time? 
                
17. Trouble with in-laws of 
mate's parents? 
                
HEALTH 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
19. Hostitalization for a 
life- threatening physical 
illness, disability, injury or 
major surgery? 
                
20. Hospitalization for a 
less serious physical 
illness, injury, or tummor 
surgery? 
                
21. Hospitalization for an 
emotional or psychiatric 
illness. 
                
22. Progression of IUV 
infection (e.g. t-cell 
decrease, developing 
symptoms or AIDs 
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23. Recovered from any of 
the above illnesses, 
disabilities, or injuries? 
                
24. Change in personal 
habits (include sleeping, 
eating, exercising, 
smoking, drinking or drug 
use)? 
                
25. Accident...Motor 
vehicle? 
                
26. Mate or spouse had 
major change in health 
status? 
                
27. Close friend or relative 
had major change in health 
status? 
                
LEGAL 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
28. Physically assaulted or 
attached? 
                
29. Physically/emotionally 
abused or raped? 
                
30. Involved in a law suit 
court case or trouble with 
the law? 
                
31. Mate or spouse 
involved in crime or legal 
mater? 
                
32. Close friend or family 
member involved in crime 
or legal matter? 
                
Money and Finance 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
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33. Took out a large 
mortgage or a loan of more 
than one- fourth of family 
income? 
                
34. Financial situation 
worsened (repossession of 
car, loan foreclosed, 
property or money lost, 
gambling losses, loss of 
income source)? 
                
35. Went on Welfare or 
Disability? 
                
36. Went off or lost 
Welfare or Disability? 
                
37. Chronic financial 
stress? 
                
FRIENDS AND FAMILY HOUSEHOLD 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
38. New person (other than 
mate) became a resident in 
the household? 
                
39. Started to live alone?                 
40. Started to live without 
any children at home? 
                
41. Someone stayed on in 
the household after he/she 
was expected to leave? 
                
42. Serious family 
argument other than with 
mate (e.g. mother, brother, 
child)? 
                
43. Serious argument with 
close friend? 
                
44. Seeing less of close 
family member other than 
mate? 
                
RESIDENCE 
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Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
45. Moved to a better 
residence or neighborhood? 
                
46. Moved to a worse 
residence or neighborhood? 
                
47. Lost a residence (e.g. 
home or apartment) 
through fire, flood, or other 
disaster, or a major 
destruction of it? 
                
DEATH 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
48. Spouse/mate died?                 
49. Spouse/mate you are 
separated or divorced from 
died? 
                
50. Child died?                 
51. Other immediate family 
member died (mother, 
father, brother, sister)? 
                
52. Other close relative (s) 
died (grandparent, aunt, 
uncle, in-laws. etc.)? 
                
53. Close friend died?                 
NEW LIFE 
Have any of these events happened to you in the 
last 12 months? 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
 
YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
55. Birth of grandchild or 
great grandchild? 
                
56. Self or close family 
member became pregnant? 
                
57. Birth or adoption of 
first child? 
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58. Birth or adoption of 
second or later child? 
                
59. Birth of grandchild or 
great grandchild? 
                
60. Found out that you 
could not have children? 
                
61. Close friend or relative 
had childbirth related 
change? 
                
OTHER 
OTHER  RECENT EXPERIENCES WHICH  
HAVE HAD AN IMPACT ON YOUR LIFE (write 
in) 
When the event 
happened, was the 
impact on your life 
When the event happened, how stressful was the 
event 
  YES NO GOOD BAD VERY SOMEWHAT LITTLE NOT 
62                 
63                 
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Brief Resilience Scale 
Please indicate the extent to which you agree with each of the following statements by 
using the following scale:  
1= Strongly disagree, 2= Disagree, 3=Neutral, 4=Agree, 5= Strongly agree 
 Strongly 
Disagree 
Disagree Neutral  Agree Strongly 
Agree 
I tend to bounce back quickly 
after hard times 
1 2 3 4 5 
I have a hard time making it 
through stressful events 
1 2 3 4 5 
It does not take me long to 
recover when something bad 
happens 
1 2 3 4 5 
It is hard for me to snap back 
when something bad happens  
1 2 3 4 5 
I usually come through 
difficult times with little 
trouble 
1 2 3 4 5 
I tend to take a long time to get 
over set-backs in my life  
1 2 3 4 5 
 
Scoring: The BRS is scored by finding reverse coding items 2, 4, and 6 and finding the mean of 
the six items. 
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Daily Nutritional Intake Questionnaire 
Date:   
          
Subject #:   
          
Avg hours sleep 
per night in the 
last week: 
  
          
Describe what you ate yesterday in the best detail you can: 
  What foods? Approx. how much?                                                              
(Use units like cup, 
ounces, fist, etc) 
What drinks? Approx. how much?                                                                         
(Use units like fluid 
ounces, cup, bottle, etc) 
What 
time? 
Breakfast           
            
            
            
            
            
            
Lunch           
            
            
            
            
            
            
Dinner           
            
            
            
            
            
            
Snacks           
            
            
            
            
            
            
Supplements/Vita
mins 
Which? How much per day? 
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Caffeine How much per 
day? 
       
  
    
       
  
Nicotine How much per 
day? 
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Daily Nutritional Intake Questionnaire (Part 2) 
 
Over the past week (WEEK days only), at what time did you most often take the supplement?  
(choose one)  
a. 1 Prior to and 1 after the workout  
b. 2 Prior to the workout 
c. 2 After the workout 
d. Other (please list and explain in the box below)  
 
 
 
 
2. Over the past week, (WEEKEND/HOLIDAY days only), at what time did you most often 
take the supplement?  (please list and explain in the box below)  
 
 
 
 
 
3. Which nutritional supplement do you think that you are taking? 
a. High nutrient 
b. Low nutrient  
In the box below, please explain why you think this way:  
 
 
 
 
